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Snf1/AMPK family members mediate the nutrient stress response in eukaryotes. In yeast, Snf1 is 
required for survival during glucose deprivation. There are three different Snf1 isoforms; each 
contains the catalytic α subunit, one of three regulatory β subunits, and the regulatory γ subunit. 
In glucose limitation, Snf1 is stimulated by activation loop phosphorylation by three partially 
redundant Snf1-activating kinases (SAKs), Sak1, Tos3, and Elm1. In glucose abundance, the 
PP1 phosphatase Glc7 dephosphorylates Snf1. We investigated the relationships between the 
three SAKs and three Snf1 isoforms, the roles of the SAK nonkinase domains, and the 
mechanism(s) controlling glucose-regulated Snf1 phosphorylation. 
Since Snf1 assembles into three complexes, the possibility existed that each SAK is 
dedicated to phosphorylating a single Snf1 isoform. To test this, we generated strains lacking 
different combinations of SAKs and β subunits. While our results indicate that the SAKs are not 
dedicated to specific Snf1 isoforms, each SAK exhibited distinct abilities to activate Snf1, 
depending on the β subunit and stress imposed on cells. 
Domain deletion analysis was employed to characterize the SAKs’ nonkinase domains. 
Deletion of Sak1 and Tos3 (but not Elm1) C-termini diminished the ability to activate Snf1. 
Deletion of the Elm1 C-terminal domain abrogated Elm1’s participation in morphogenetic 
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signaling. Thus, the SAK C-terminal domains contribute to pathway specificity. Additional 
deletion mutants revealed an N-terminal Sak1 motif essential for Snf1 signaling. These data 
demonstrate that nonkinase N- and C-terminal domains are critical for SAK pathway 
specification. 
Snf1 phosphorylation status is regulated by integration of the reaction rates of 
phosphorylation by the SAKs and dephosphorylation by Glc7. We sought to determine which 
reaction(s) is glucose-regulated. SAKs immunoprecipitated from extracts of cells grown in high- 
and low-glucose conditions exhibited similar activity toward Snf1, suggesting the SAKs exhibit 
constitutive activity. Snf1 dephosphorylation, however, is glucose-regulated. When de novo 
phosphorylation was inhibited, Snf1 phosphorylation was stable in low glucose but rapidly lost 
upon glucose addition. Glc7 catalytic activity is not glucose-regulated since another Glc7 
substrate was dephosphorylated in both glucose conditions. Therefore, Snf1 phosphorylation 
status is controlled by Snf1’s availability to serve as a Glc7 substrate. 
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1.0  INTRODUCTION 
The AMP-activated protein kinase (AMPK) is considered the “fuel gauge” of the eukaryotic cell 
(76). It is activated under conditions of energy stress, particularly when the AMP:ATP ratio is 
elevated. Once active, AMPK functions to modulate the metabolic program of the cell, 
phosphorylating both transcription factors and metabolic enzymes. The net effect of AMPK 
activation is the inhibition of ATP-consuming anabolic processes with the concomitant 
stimulation of ATP-generating catabolic processes (75). 
AMPK homologues have been found in all higher eukaryotes with sequenced genomes 
(77). The Snf1 serine/threonine protein kinase is the Saccharomyces cerevisiae AMPK 
homologue (25, 130, 204). Like the mammalian enzyme, Snf1 is activated by energy stress. 
Glucose is the preferred carbon source of yeast, and a major function of Snf1 is the promotion of 
cellular survival under conditions in which glucose is scarce; in the absence of glucose, Snf1 is 
required for the utilization of alternative carbon sources (for example, fermentation of raffinose 
and sucrose or respiration of glycerol and ethanol) (77). 
Snf1 is a basic-directed kinase with a loosely defined consensus substrate recognition 
sequence: φxRxxSxxxφ (φ is a hydrophobic residue; x is any amino acid; R is a basic amino acid, 
usually arginine; and S is the phosphorylated serine or threonine) (172). When cells are grown in 
glucose-limiting conditions, Snf1 phosphorylates a number of protein substrates, including 
transcription factors, chromatin components, and metabolic enzymes. A non-exhaustive 
  1
  2
schematic representation of the Snf1 signaling response to changes in glucose availability is 
depicted in Figure 1.1. Snf1 phosphorylates and thereby regulates the activity of both 
transcriptional activators and repressors. One well-characterized Snf1 substrate is Mig1, a Cys2-
His2 zinc finger transcriptional repressor. Upon phosphorylation of four sites in the Mig1 protein 
by Snf1 (172, 186), the interaction of Mig1 with the co-repressors Ssn6 and Tup1 is abolished, 
phosphorylated Mig1 is exported from the nucleus by the exportin Msn5 (48), and glucose-
associated transcriptional repression is relieved (145). Among the genes regulated by Mig1 (in 
conjunction with Ssn6 and Tup1) are those which promote the utilization of non-glucose carbon 
sources, including SUC2, the gene encoding invertase (122, 185). Invertase catalyzes the 
conversion of sucrose (to fructose and glucose) and raffinose (to fructose and melibiose) (67, 
181). Snf1 phosphorylates and activates the transcriptional activators Sip4 and Cat8 (87, 151, 
193). Additionally, when recruited to a promoter, Snf1 may directly stimulate transcription by its 
interaction with RNA polymerase II (111). A single laboratory has suggested that Snf1 may 
modulate chromatin structure by phosphorylating histone H3 serine 10 in a manner that affects 
subsequent histone modification and transcriptional activity (120).  
Snf1 also phosphorylates and modulates the catalytic activity of metabolic enzymes, 
effectively downregulating biosynthetic pathways under conditions of glucose limitation. For 
example, Snf1 phosphorylates and inhibits the activity of Acc1 (204), acetyl coA carboxylase, 
the rate-limiting enzyme in fatty acid biosynthesis (163) and a regulator of INO1 transcription 
(169). In addition to responding to glucose limitation, Snf1 is also involved in the adaptations to 
inositol limitation (167), sodium and lithium ionic stress (211), nitrogen limitation (112), 
alkaline pH (148), and genotoxic stress (53) and has roles in cellular aging (9), diploid 
pseudohyphal growth, haploid invasive growth (112), meiosis (94), and autophagy (197). 
 Figure 1.1 Snf1 signaling in response to changes in glucose availability. 
Snf1 is phosphorylated and active in low-glucose conditions. Three partially redundant kinases, Sak1, Tos3, and 
Elm1, phosphorylate the Snf1 activation loop. Under conditions of glucose abundance, the Reg1/Glc7 PP1 
dephosphorylates Snf1. When active, Snf1 phosphorylates and stimulates several transcriptional activators, 
including Cat8, Sip4, Gln3, Hsf1, and Msn2; phosphorylates and inhibits the transcriptional repressor Mig1; 
phosphorylates isoforms of histone 3 (Hht1 and Hht2), priming them for acetylation, thereby facilitating 
transcription; and phosphorylates and inhibits acetyl coA carboxylase (Acc1), a rate-limiting enzyme in fatty acid 
biosynthesis. 
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1.1 IDENTIFICATION AND INITIAL CHARACTERIZATION OF SNF1 
SNF1 (sucrose non-fermenting 1) was originally identified in a genetic screen for yeast mutants 
which failed to ferment sucrose but were able to utilize glucose (27) and later shown to be allelic 
with CCR1 (36) and CAT1 (215). It was found to be distinct from the gene SUC2, encoding the 
enzyme invertase, which hydrolyzes sucrose to glucose and fructose.  SNF1 mutation did reduce 
the expression of SUC2, however, suggesting a role for SNF1 in glucose derepression. Yeast 
with SNF1 mutations grew more slowly than wild-type cells in low-glucose conditions and were 
defective in fermenting galactose and maltose as well as respiring nonfermentable carbon 
sources (27). Early studies indicated that SNF1 RNA levels were not regulated by glucose 
abundance (31). Integration of cloned SNF1 DNA in yeast by homologous recombination 
facilitated the mapping of the SNF1 locus on the right arm of chromosome IV, not near other 
previously mapped mutations (30). 
 Subsequent to the identification and chromosomal mapping of SNF1, researchers sought 
to identify other genetically and biochemically interacting gene products by screening for yeast 
mutants which recovered the capacity to utilize alternative carbon sources in the absence of a 
functional SNF1 gene. The revertants were termed ssn (supressor of snf1) mutations 1 through 8 
(28). Several of the genes mutated in this study were later determined to be components of the 
general RNA polymerase II (RNAP II) transcriptional apparatus. SSN2, SSN4, SSN5, and SSN7 
(allelic to SRB9, SIN4, SRB8, and ROX3, respectively) encode subunits of the RNAP II mediator 
complex (173).  SSN3 and SSN8 (allelic to SRB10 and SRB11, respectively) encode an RNAP II-
associated cyclin-dependent kinase and cyclin pair involved in RNAP II carboxy-terminal 
domain phosphorylation (118). In contrast to these general transcription factors, SSN1 and SSN6 
were ultimately found to be allelic to the genes encoding the Mig1 zinc finger transcriptional 
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repressor and Cyc8 co-repressor (which functions in complex with Tup1), respectively, which 
work together to repress SUC2 transcription in glucose abundance; relief of repression by these 
transcription factors was later shown to require Snf1 activity toward Mig1 (191). The implication 
of the SSN genes in transcriptional control highlights the important role of Snf1 in modulating 
gene expression.  The Snf1 protein was found to be a kinase; this provided evidence that the 
signaling of glucose limitation would be mediated at least in part by protein phosphorylation 
(29). 
 
1.2 YEAST: A MODEL SYSTEM FOR STUDYING AMPK/SNF1 SIGNALING 
Yeast represents a good model system in which to study the AMPK/Snf1 signaling pathways. 
The AMPK/Snf1 pathway is highly conserved, and the study of AMPK in mammalian cells and 
Snf1 in yeast has been a mutually beneficial endeavor. In multiple cases, findings in one field 
have led directly to analogous discoveries in the other. For example, labs studying the 
mammalian AMPK purified the enzyme and demonstrated that it was a heterotrimer (43). When 
the molecular identities of the AMPK subunits were determined, it became clear that the 
previously identified yeast genes SNF1 and SNF4 encoded α and γ subunits of the yeast 
homologue of AMPK. Furthermore, yeast genetic analysis suggested that the AMPK γ subunit 
was an activator of the kinase complex (discussed below) (129) as has proven to be true (82). 
Another instance of the synergistic cooperation between research fields was the identification of 
the Snf1-activating kinases (SAKs) in the yeast system (92, 180), which led to the rapid 
identification of the mammalian AMPK kinases (AMPKKs) (81, 98, 203). Additionally, ease of 
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genetic manipulation and established biochemical assays make yeast an attractive organism for 
the investigation of conserved signaling pathways. By studying this pathway in both yeast and 
mammalian systems, progress in both fields has been greatly accelerated. Towards the end of 
better understanding the AMPK signaling pathway, determining how the Snf1 protein kinase is 
regulated in response to energy and nutrient stress is central to the work presented in this 
manuscript (Chapters 2-4). A brief review of the mechanisms by which the protein kinases in 
yeast are regulated follows. 
1.3 MECHANISMS OF KINASE REGULATION 
Reversible protein phosphorylation is a ubiquitous post-translational modification in prokaryotes 
and eukaryotes. It is critically involved in the regulation of nearly all cellular processes and 
signaling pathways. Protein kinases, the enzymes that catalyze the phosphotransfer reaction, 
constitute 2% of the genes of any given eukaryotic genome (125). Few of these kinases are 
constitutively active; unregulated activity would be deleterious or lethal to cells in the cases of 
most protein kinases. Cells have thus developed a variety of finely tuned mechanisms to 
precisely control the activities of these enzymes, including phosphorylation and 
dephosphorylation, protein binding, binding of nonprotein ligands, protein accumulation, and 
subcellular localization (as reviewed by Rubenstein and Schmidt in 2007, from which this 
section (1.2: Mechanisms of Kinase Regulation) was adapted) (155). 
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1.3.1 Phosphorylation and dephosphorylation 
One of the most well-characterized mechanisms by which protein kinases are activated is 
phosphorylation of the activation loop (also called the T loop), the flexible polypeptide segment 
that connects the N and C lobes of the kinase domain (141). Activation loops are typically 20 to 
35 residues long and bounded by the conserved residues DFG at the segment’s N terminus and 
APE at the C terminus. The loop itself is less well conserved but often contains one or two 
conserved phosphorylatable residues (serine, threonine, or tyrosine). The conformation of the 
activation loop relative to the kinase domain changes with its phosphorylation status. The 
conformational shift controls the activity state of the kinase by either relieving the steric 
hindrance of the substrates to the active site, aligning the catalytic residues, or both (3, 141). 
Only 37 of 117 yeast protein kinases in the eukaryotic protein kinase family are currently known 
to be activated by phosphorylation of one or more critical residues within the activation loop. 
However, sequence conservation suggests that many more kinases may ultimately be added to 
this list. Additionally, many kinases are regulated by phosphorylation sites outside their 
activation loops. In contrast to activation loop phosphorylation, which is always activating, 
phosphorylation outside the activation loop can either stimulate or inhibit a kinase (155) 
For those studying the regulation of protein kinases, it is not difficult to develop (even 
unwittingly) a kinase-centric worldview, whereby the phosphorylation events regulating 
pathways and enzymes are analyzed in terms of phosphate addition alone. In reality, the 
phosphorylation statuses of most substrates are a reflection of the equilibrium of phosphate 
addition by a kinase and phosphate removal by a phosphatase. At the moment, kinases are better 
studied than phosphatases. Indeed, in analysis of phosphorylation sites of protein kinases, the 
responsible kinase has been identified in many more cases than has the cognate phosphatase. 
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Nonetheless, the dephosphorylation of protein kinases has regulatory consequences and can be 
either activating or inactivating (155). 
1.3.2 Binding proteins and nonprotein ligands 
Protein-protein interaction is another major regulatory motif controlling the activities of protein 
kinases. Members of each major group of protein kinases are regulated by interaction of the 
kinase domain with other protein domains in either cis or trans. Association with protein binding 
partners can modulate the activation states of kinases in multiple ways and can lead to 
stimulation or inhibition of kinase activity. Elegant structural studies have elucidated the manner 
by which protein binding dictates the activities of several kinases (102, 115, 146). While many 
kinases are controlled by their interactions with other proteins or protein domains, a few are 
regulated by binding nonprotein ligands. In all documented cases in yeast, these interactions 
stimulate the activities of the respective kinases (155). 
1.3.3 Accumulation and localization 
Kinases are also regulated by management of protein accumulation. Hsp90 and its co-chaperone 
Cdc37 play an important role in the folding and accumulation of many if not most yeast protein 
kinases (124). The interaction of kinases with chaperones may also regulate kinase activity by 
controlling the transition between active and inactive conformations (1, 52, 70). The abundance 
of specific kinases may be modulated by changes in expression at the level of mRNA, protein, or 
both. mRNA and protein levels can be regulated at the stage of generation (transcription or 
translation) or stability (for example, protein degradation following ubiquitination (23, 196)). 
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Control of subcellular localization is another mechanism by which protein kinases may be 
regulated. Like protein accumulation, this mechanism does not necessarily involve a change in 
intrinsic catalytic activity but serves to position the enzyme at the right place and time to perform 
its respective function (155). 
The primary goal of the work presented in the following chapters is to better understand 
the regulation of the Snf1 kinase in yeast. Prior research has demonstrated that Snf1 and its 
mammalian homologue AMPK are regulated by several of the mechanisms described in section 
1.2 (as will be detailed below). Both are phosphorylated on their activation loops by distinct 
upstream activating kinases. Both seem to be controlled by regulated interactions with protein 
binding partners. Changes in subcellular localization may direct these kinases to their cognate 
substrates. Finally, AMPK activity is modulated by non-protein ligand interaction; whether this 
is the case for Snf1 remains an open question.  
1.4 HETEROTRIMERIC STRUCTURE OF AMPK/SNF1 
The mammalian AMPK and yeast Snf1 kinase exist as heterotrimers, composed of a catalytic α 
subunit, scaffolding and regulatory β subunit, and regulatory γ subunit (161) (see Table 1.1 for 
central components of the Snf1 and AMPK signaling pathways). The mammalian genome 
encodes two α subunits (α1 and α2), two β subunits (β1 and β2), and three γ subunits (γ1, γ2, and 
γ3), some of which are expressed in a tissue-specific manner (34, 123, 192). Several of these 
subunits also exist as multiple splice isoforms (154, 192). Thus, the mammalian AMPK enzyme 
can exist in over 12 alternative forms, as defined by the differential subunit identities. By 
contrast, yeast express only one catalytic α subunit (the Snf1 protein), three different β subunits
Table 1.1 Central components of the yeast Snf1 and mammalian AMPK signaling pathways. 
 
Role Yeast: Snf1 pathway 
Mammalian: 
AMPK pathway 
Catalytic 
α subunit Snf1 
α1 
α2 
α3 
Regulatory/ 
scaffolding 
β subunit 
Sip1 
Sip2 
Gal83 
β1 
β2 
Heterotrimeric 
kinase 
complex 
Regulatory 
γ subunit Snf4 
γ1 
γ2 
γ3 
Upstream activating kinases 
Sak1 
Tos3 
Elm1 
LKB1 
CaMKKα/β 
Tak1 (?)a 
Inactivating phosphatase 
 
Glc7 
 
PP2C 
Phosphatase targeting 
subunit 
 
Reg1 
 
nab 
 
a Tak1 phosphorylates the Snf1 kinase activation loop in yeast cells and the AMPK activation loop in vitro, but its 
role as a legitimate in vivo AMPKK is yet to be established. 
b na, not applicable. Orthologous component is not believed to be present in this system. 
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 Figure 1.2 Snf1 structure and activation. 
The active enzyme is a heterotrimer consisting of a catalytic α subunit (Snf1), one of three scaffolding and 
regulatory β subunits (Sip1, Sip2, or Gal83), and a regulatory γ subunit (Snf4). Snf1 is activated in low glucose by 
two distinct steps: phosphorylation of an activation loop threonine by one of three partially redundant Snf1-
activating kinases (Sak1, Tos3, or Elm1) and interaction of Snf4 with the Snf1 autoinhibitory domain. In high 
glucose, Snf1 is inactivated by activation loop dephosphorylation by the PP1 Glc7 (targeted to Snf1 by Reg1) and 
abolition of the Snf1/Snf4 interaction. 
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(Sip1, Sip2, and Gal83), and one γ subunit (Snf4), yielding three potential heterotrimers defined 
by the β subunit identity (Figure 1.2). 
The α subunit of Snf1 and AMPK consists of an N-terminal catalytic kinase domain, 
followed by a C-terminal regulatory domain. The regulatory domain contains sequences involved 
in interaction with the β and γ subunits. The α subunit autoinhibitory motif (discussed below), 
just C-terminal to the kinase domain, is believed to interact alternately with the α subunit 
catalytic domain within the same polypeptide (in the case of the autoinhibited, inactive enzyme)
and γ subunit (in the case of the active enzyme) (103). The α subunit C-terminal region interacts 
with the β subunit (104). 
Sip1 and Sip2 were identified in a yeast two-hybrid screen for Snf1-interacting proteins 
(209). Gal83, originally found to be involved in the regulation of galactose metabolism (127), 
was recognized as a Snf1-interacting protein based on homology with Sip2 (210). The C-
terminal residues of the β subunits in yeast and mammals contain conserved sequences that 
mediate interaction with the α and γ subunits of the heterotrimer (104, 210). The β subunit N-
terminal domains are more variable; indeed, it is these divergent sequences that direct the 
glucose-regulated subcellular localization of the Snf1 complexes of which they are constituents. 
In high glucose conditions, all three β-subunit-specific Snf1 heterotrimer isoforms are 
cytoplasmic. In glucose limitation, the Snf1-Gal83-Snf4 heterotrimer translocates to the nucleus, 
Snf1-Sip1-Snf4 relocalizes to the vacuolar membrane, and Snf1-Sip2-Snf4 remains cytoplasmic 
(194). Additional elements within the β subunit N termini may also confer specificity of Snf1 
substrate selection (161, 193). Sip2 and Gal83 contain an N-terminal glycogen-binding domain, 
and Gal83 has been shown to bind glycogen in vivo (198). Sip1 and Sip2 contain myristoylation 
sites at their N termini; the Sip1 myristoylation is required for its low-glucose vacuolar 
localization (85). 
Early studies indicated that the β subunits were dispensable for Snf1 function in vivo (59, 
210). However, these analyses relied upon data generated from yeast strains in which the β 
subunits were incompletely deleted. When the entire coding sequences for all three β subunits 
were eliminated, cells exhibited a Snf- phenotype: cells were unable to grow on alternative non-
glucose carbon sources, did not induce invertase in response to glucose limitation, and Snf1 
targets did not become phosphorylated (161). Therefore, the β subunits are required for Snf1 
function. 
Like Snf1, the γ subunit Snf4 (allelic to CAT3) was identified in a screen for mutants 
which failed to utilize sucrose (58, 140), and cells exhibit a Snf- phenotype in the absence of 
Snf4 (32, 129). Mammalian and yeast γ subunits contain two Bateman domains (Bateman 1 and 
Bateman 2), each composed of two CBS motifs (CBS1 through CBS4) (12). Each Bateman 
domain in the mammalian enzyme is capable of binding one molecule of AMP or ATP in vitro 
(164), and the binding of AMP has been shown to stimulate AMPK in multiple manners (82). 
Whether the homologous regions in yeast Snf4 bind AMP (or any other ligand) has long been a 
matter of speculation. 
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1.5 REGULATION OF AMPK/SNF1 
1.5.1 AMPK/Snf1 activation loop phosphorylation 
The activation of Snf1 and AMPK requires at least two distinct events: activation loop 
phosphorylation and changes in intermolecular interactions within the enzyme heterotrimer (129) 
(Figure 1.2). One critical step is phosphorylation of an α subunit activation loop threonine 
(threonine 210 for Snf1, threonine 172 for AMPK α1) by upstream activating kinases (79, 92, 
129). Under conditions of energy limitation, Snf1 is phosphorylated by one of three partially 
redundant Snf1-activating kinases (SAKs), Sak1 (formerly known as Pak1), Tos3, and Elm1 (92, 
180). The primary upstream activating AMPK kinase (AMPKK) in most mammalian cell types 
is the tumor suppressor kinase LKB1 (203). In some cells where AMPK activation may be 
regulated by conditions other than energy stress (for example, neural tissue), AMPK is 
phosphorylated by the calcium/calmodulin-dependent protein kinase kinases α and β 
(CaMKKα/β) in response to increases in cellular calcium levels (81, 98, 202). When LKB1 and 
CaMKKα/β are expressed in place of the three SAKs in yeast, Snf1 is phosphorylated in a 
glucose-regulated fashion (93). Finally, the mammalian Tak1 kinase (transforming growth 
factor-β activated protein kinase 1) has been shown to phosphorylate Snf1 when expressed in 
yeast and phosphorylate AMPK in vitro and may represent an additional physiological AMPKK 
in mammals (131). 
The identification of the SAKs was a major breakthrough in the understanding of the 
Snf1 and AMPK signaling pathways. Sak1 was initially found to co-purify with Snf1 in 
proteomic studies of protein/protein interactions (68, 89). Subsequent studies demonstrated that 
Sak1 phosphorylated Snf1 in vitro at the critical Snf1 activation loop threonine. However, when 
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SAK1 was deleted, Snf1 was still found to be phosphorylated in a glucose-regulated fashion, 
suggesting that Sak1 was not the only SAK in the yeast cell (138). Further experiments with a 
GST-fusion kinase library demonstrated that Elm1, a related kinase could phosphorylate and 
activate AMPK and Snf1 in vitro. Yet, Snf1 was still phosphorylated in cells lacking SAK1 and 
ELM1. Finally, Tos3, the third SAK, was identified by sequence homology to Sak1 and Elm1 
and was also found to phosphorylate Snf1 in vitro. When the genes encoding all three SAKs 
(SAK1, TOS3, and ELM1) were deleted, Snf1 was no longer phosphorylated in conditions of 
glucose limitation, confirming that these three proteins represent the complete complement of 
SAKs (180). Cells that lack all three kinases exhibit a Snf- phenotype. Any one of the three 
SAKs is sufficient to confer a SNF+ phenotype (92, 180). 
Sak1, Tos3, and Elm1 are members of the CaMKK family of enzymes. They each 
contain a highly conserved kinase domain that is flanked by highly variable and poorly 
functionally defined N- and C-terminal sequences. There exists an approximately 25-amino-acid 
sequence of homology of unknown significance in the C-termini of Sak1 and Tos3 (Figure 3.1b). 
Sak1 (Snf1-activating kinase 1) was originally named Pak1 (polymerase alpha kinase) 
when it was identified in a screen for suppressors of mutations in DNA polymerase α (95); 
however, following its identification, no subsequent interaction of the kinase with polymerase α 
was established. To avoid confusion with p21-activated kinases (PAKs) (90), Pak1 was renamed 
Sak1. Tos3 (target of SBF 3) was originally identified in a screen for targets of the cell-cycle-
regulated transcription factor SBF (101). However, no role for Tos3 in the control of cell cycle 
has been further elucidated.  
Unlike Sak1 and Tos3, whose only characterized role in the cell is the activation of Snf1, 
Elm1 has another distinct function: maintaining normal cellular morphology. Cells that lack 
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Elm1 display an elongated morphology for which the kinase was named (17). Elm1 localizes to 
the yeast cell bud neck where it participates in the coordination of cell growth and cell division 
(20, 97, 132). It is involved in the organization of septins at the site of bud emergence during G1 
(176). 
1.5.2 Inactivation of AMPK/Snf1 by dephosphorylation 
Upon a return to energy-rich conditions, AMPK and Snf1 are inactivated by dephosphorylation 
of their respective activation loop threonine residues. In contrast to the kinases catalyzing the 
phosphotransfer reaction in yeast and mammals, the AMPK- and Snf1-inactivating phosphatases 
do not seem to be in the same family of enzymes. The mammalian AMPK was shown to be 
dephosphorylated in vitro by the PP2Cα phosphatase (44). PP2Cα was subsequently found in a 
complex with AMPK purified from liver tissue and is believed to be the phosphatase responsible 
for AMPK activation loop dephosphorylation in vivo (159). 
In S. cerevisiae, Glc7, a member of the protein phosphatase 1 (PP1) family in yeast, 
dephosphorylates Snf1 in high glucose (Figure 1.2). GLC7 is an essential gene (61) and was 
genetically implicated in glucose signaling when a mutant variant (Glc7-T152K) resulted in the 
derepression of glucose-repressed transcription of the genes SUC2 and MAL3 (188). In addition 
to Snf1 inactivation, Glc7 is involved in a wide variety of cellular processes, including meiosis 
(10, 189) and sporulation (150), cell cycle and mitotic control (8, 62, 88), glycogen metabolism 
(61), ion homeostasis (199), vesicular membrane fusion (147), and cell wall integrity (8). 
Like PP1 phosphatases of other species, the yeast Glc7 is targeted to its specific 
substrates by distinct targeting subunits. The accessory protein which targets Glc7 to Snf1 in 
glucose abundance is the Reg1 protein (187). Cells lacking Reg1 exhibit constitutively elevated 
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Snf1 activation loop phosphorylation and activity, regardless of glucose abundance (129). 
Similarly, mutations which disrupt the interaction between Reg1 and Glc7 (such as Glc7-T152K 
or Reg1-F468R) render Snf1 constitutively active without affecting other essential functions of 
Glc7 (160). Intriguingly, while Reg1 is believed to be required to mediate Glc7 
dephosphorylation of Snf1 in high glucose conditions, yeast two-hybrid data has suggested that 
Reg1 associates preferentially with Snf1 in low glucose abundance (121). Additionally, Reg1 is 
phosphorylated in glucose limitation in a Snf1-dependent manner (160). The functional 
significance of this modification is unclear. 
1.5.3 Regulation by the AMPK/Snf1 γ subunit 
The second step in AMPK/Snf1 activation is mediated by the γ subunit. AMPK was so named 
because it was first defined as a kinase stimulated by AMP (212). Under conditions of energy 
stress (and elevated AMP:ATP ratio), AMP binds the mammalian γ subunit. AMP binding of the 
γ subunit of mammalian AMPK stimulates the enzyme in at least two manners: it stimulates the 
intrinsic activity of the enzyme and stabilizes the phosphorylation of the α subunit activation 
loop (82). The exact mechanism whereby AMP binding stimulates intrinsic AMPK activity is not 
clear, but it presumably involves relief of autoinhibition of the catalytic α subunit kinase domain 
by the C-terminal regulatory domain of the same subunit (40). The mammalian γ subunit can 
also bind ATP (under conditions of energy abundance and a lower AMP:ATP ratio), and this 
binding is inhibitory of kinase activity. The binding of AMP or ATP is mutually exclusive, and 
mammalian γ subunits exhibit a significantly greater affinity for AMP than ATP (164). 
In contrast to the mammalian system, the yeast γ subunit, Snf4, has not been shown to 
bind AMP, ATP, or any ligand. In fact, purified Snf1 heterotrimer is not stimulated by AMP in 
vitro (130, 204). Additionally, an amino acid required for mammalian γ subunit coordination of 
AMP has not been conserved in yeast. Mutation of histidine 151 in human γ1 to glycine largely 
abolishes AMP-dependence of AMPK activation; the corresponding residue in Snf4 is glycine 
145 (2). However, several other residues critical for AMPK stimulation by AMP are conserved 
in Snf4, and Snf4 is critical for efficient activation of Snf1 in low glucose (Figure 1.2) (32, 129). 
Like the mammalian system, Snf1 contains an autoinhibitory sequence C-terminal to the kinase 
domain. This sequence alternately binds the Snf1 catalytic domain (in glucose abundance, 
presumably an inhibitory interaction) and Snf4 (in glucose limitation, presumably a stimulatory 
interaction) (103). Snf4 receives an as yet undefined low-glucose signal triggering its relief of 
Snf1 autoinhibition. Mutations within the Snf1 catalytic core have been identified which render 
regulated kinase activity independent of Snf4 (114). 
1.6 AMPK AND HUMAN HEALTH 
1.6.1 AMPK and Type II Diabetes 
The AMPK signaling pathway is intricately connected with multiple aspects of human health, 
making it an important area of investigation. Of chief significance is the role of AMPK in 
regulating cellular and whole-organism energy homeostasis. AMPK in skeletal and cardiac 
muscle is normally activated by exercise and other conditions that deplete stores of ATP (135, 
136). Over 15 million Americans suffer from Type II Diabetes; at least a quarter of these patients 
are undiagnosed (33, 73). AMPK mediates at least in part, and perhaps in whole, the therapeutic 
effects of the anti-diabetic medication metformin (Glucophage), the most widely prescribed 
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medication used to treat patients with Type II Diabetes (214). The exact mechanism by which 
metformin results in AMPK activation is not yet universally agreed upon. Initial reports 
suggested that AMPK activation in response to metformin was adenine-nucleotide-independent 
(80), potentially involving the generation of mitochondrially derived reactive nitrogen species 
and increased association of AMPK with its activating kinase, LKB1 (216). While more recent 
studies have confirmed a role for LKB1 in the mediation of metformin’s therapeutic effects (166, 
207), some investigators have posited that metformin functions as a mitochondrial poison, 
inhibiting respiratory complex I, with the ultimate effect of increasing the AMP:ATP ratio (22). 
Regardless of metformin’s mechanism of action, it is clear that activation of the AMPK signaling 
pathway is beneficial to patients suffering from Type II Diabetes. 
1.6.2 AMPK and Wolff-Parkinson-White Syndrome 
Dominant mutations in the γ2 subunit of AMPK contribute to cardiac hypertrophy associated 
with aberrant excessive glycogen accumulation and ventricular pre-excitation in a condition 
known as Wolff-Parkinson-White Syndrome. It is not clear whether these mutations result in the 
gain or loss of AMPK function in cardiac tissue of afflicted patients (42). Ongoing investigation 
has failed to yield the mechanism(s) by which AMPK mutation results in cardiopathological 
conditions (49). 
1.6.3 LKB1, AMPK, and cancer 
The AMPK signaling pathway is also involved in cancer. Germline inactivating mutations in 
LKB1, the primary AMPK-activating kinase, have been implicated as causative of Peutz-Jeghers 
  19
Syndrome (PJS), a rare autosomal dominant cancer (86). Patients with PJS exhibit a 
predisposition to recurrent colon polyps and lesions as well as a high frequency of benign 
hamartomas and malignant intestinal tumors. LKB1 is a rare example of a kinase that functions 
as a tumor suppressor. More study is required to determine how mutations in LKB1 result in this 
condition (126). Sporadic mutations in LKB1 also appear in a small but significant number of 
cases of pancreatic and non-small-cell lung cancers (158). 
Finally, pharmacological activation of AMPK has been investigated as a potential anti-
cancer therapeutic (134). Recent studies have shown that AMPK activation inhibits the growth of 
multiple myeloma cell lines (13), colon cancer cell lines (24, 178), and glioma cell lines (100). 
Other investigators have demonstrated an anti-tumor effect of AMPK inhibition in certain cell 
types (107). 
1.7 REGULATION OF GLUCOSE SIGNALING UPSTREAM OF SNF1 
When the investigation described herein commenced, the Glc7-Reg1 PP1 had long been believed 
to be the phosphatase responsible for Snf1 dephosphorylation. By contrast, the identities of the 
SAKs had just recently been reported. Virtually nothing was known regarding the mechanisms 
controlling Snf1 phosphorylation in response to glucose availability. Thus, the purpose of this 
study was to better understand how Snf1 activation loop phosphorylation is regulated by glucose 
concentration. The primary objective was to determine if and how SAK and PP1 activity toward 
Snf1 is responsive to changes in environmental glucose levels. 
Many questions surround the regulation of Snf1 activation loop phosphorylation. First, 
why are there three distinct SAKs? It seems plausible, if not likely, that each SAK might display 
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some specialization of function. Are the three SAKs completely interchangeable, or is each SAK 
dedicated to the activation of a distinct β-subunit specific isoform of Snf1? Are the SAKs 
differentially required for Snf1 activation under distinct stress conditions? The question of SAK 
specificity for Snf1 isoforms and stress conditions will be addressed in the second chapter. 
Additionally, little is known about the nature and regulation of the SAKs. Each of the 
three SAKs shares a conserved kinase domain, but the sequences N- and C-terminal to the 
catalytic segment are highly divergent. Are these domains required for the activity or regulation 
of the SAKs? The functions of these potential regulatory domains will be discussed in the third 
chapter. 
Importantly, the mechanism by which Snf1 activation loop phosphorylation regulation is 
controlled remains an unanswered question. Clearly, the phosphorylation state of Snf1 at any 
particular moment is a reflection of the integration of two reaction rates: the rate of phosphate 
addition by the SAKs and the rate of phosphate removal by the inactivating phosphatase, Glc7-
Reg1. Initial investigation of the events upstream of Snf1 phosphorylation have focused on 
phosphate addition by the SAKs; however, it has not been demonstrated that SAK activity is in 
fact responsive to changes in glucose availability. Thus, the fourth chapter will explore whether 
the catalytic activities of the SAKs, the inactivating phosphatase, or both are regulated by 
fluctuations in glucose concentration. 
It is hoped that clearer elucidation of the mechanisms of Snf1 signaling in 
Saccharomyces cerevisiae will lend themselves to analogous findings with respect to the human 
AMPK signaling pathway. Such discoveries may enable better therapeutic exploitation of the 
AMPK pathway in the development of drugs for the treatment of human conditions, including 
metabolic disorders, cancer, and heart disease. 
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2.0  SNF1 KINASE COMPLEXES WITH DIFFERENT BETA SUBUNITS DISPLAY 
STRESS-DEPENDENT PREFERENCES FOR THE THREE SNF1-ACTIVATING 
KINASES 
Rhonda R. McCartney, Eric M. Rubenstein, and Martin C. Schmidt (2005). 
Current Genetics 47, 335-44. 
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 2.1 INTRODUCTION 
Members of the Snf1/AMP-activated protein kinase family play important signaling roles under 
conditions of nutrient stress in diverse species of eukaryotes, ranging from unicellular yeast to 
plants, insects, and vertebrates. In Saccharomyces cerevisiae, fermentation of glucose is the 
preferred mode of growth and does not require Snf1 kinase. In contrast, Snf1 kinase is required 
for fermentation of alternative carbon sources and for aerobic growth on non-fermentable carbon 
sources (77). In laboratory strains grown in glucose medium, once the glucose is depleted, Snf1 
kinase becomes active as cells prepare to switch to aerobic metabolism (26). Many of the genes 
whose expression is induced at the diauxic shift are not induced properly in cells lacking Snf1 
kinase (213). 
The Snf1 kinase complex is a heterotrimer composed of one α, one β, and one γ subunit. 
The α subunit contains the catalytic kinase domain and is encoded by the SNF1 gene (29). The γ 
subunit, encoded by the SNF4 gene, plays a regulatory role and is required for the full activation 
of Snf1 (32). The β subunit physically interacts with both the α and γ subunits and may act in 
part to hold the heterotrimer together (104). S. cerevisiae express three distinct β subunits 
encoded by the SIP1, SIP2, and GAL83 genes. At least one of the β subunits must be expressed 
for Snf1 activity in vivo (161). The presence of three distinct isoforms of the Snf1 kinase 
suggests that the β subunits may provide for specialization of function. Indeed, the β subunits 
control the subcellular localization of the kinase (194) and play a role in substrate selection (161, 
193). 
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Activation of Snf1 kinase is a complicated process involving at least two steps (129). 
Under conditions of glucose limitation, the Snf4 protein binds to and abrogates the effect of an 
inhibitory domain present in the C-terminus of the Snf1 protein (103). A second step required for 
Snf1 activation is the phosphorylation of a conserved threonine residue in the Snf1 activation 
loop by a distinct upstream kinase (129). We identified the Sak1 kinase of S. cerevisiae as one of 
the Snf1-activating kinases. Sak1 associates with Snf1 under conditions of glucose limitation and 
is capable of promoting the phosphorylation of the Snf1 activation loop in vitro and in vivo 
(138). However, deletion of the SAK1 gene did not interfere with Snf1 activation, suggesting that 
additional Snf1-activating kinases were present. Recently, we and others determined that the full 
complement of Snf1-activating kinases was composed of three related kinases: Sak1, Tos3, and 
Elm1 (92, 180). 
Relatively little is known about the Sak1 and Tos3 kinases. Sak1 was isolated as a high-
copy suppressor of mutations in the DNA polymerase α gene and named polymerase α kinase 
(95). TOS3 was identified in a genomic screen for promoters bound by the cell cycle-regulated 
transcription factor SBF (101). The name TOS stands for target of SBF. Numerous potential 
targets for SBF were identified, and many play roles in budding and cell wall biosynthesis. The 
TOS3 gene promoter contains at least one potential binding site for SBF, although expression of 
TOS3 mRNA does not appear to be cell cycle-regulated (35, 175). Elm1 kinase has been 
intensively studied by several groups, and its involvement in the Snf1 kinase pathway was 
unanticipated. Mutations in ELM1 were first isolated by virtue of their elongated morphology 
(65, 110). Elm1 protein is localized at the bud neck (20), where it assembles in a complex with 
other proteins (182) and plays a role in controlling bud emergence and septin organization (176). 
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The finding that Elm1 also functions in carbon source-sensing pathways (92, 180) may reflect 
the integration of carbon source-response pathways with filamentous growth pathways (41). 
In this study, we examine whether the three upstream kinases exhibit a specialization of 
function. The facts that there are three upstream kinases for Snf1 and that the Snf1 kinase 
associates with one of three different β subunits lead to the very simple hypothesis that each 
upstream kinase is dedicated to the activation of one isoform of the Snf1 kinase complex. 
Alternatively, the three upstream kinases may be promiscuous activators of all three isoforms of 
the Snf1 kinase. A similar study reported that the three Snf1-activating kinases were not 
dedicated to a specific isoform of Snf1 but that the Sak1 kinase played an important role in 
controlling the activity and localization of the Gal83 isoform in response to glucose stress (84). 
We report here that the different isoforms of Snf1 kinase can be activated by different upstream 
kinases and that the activating kinase preference varies, depending on the stress to which the 
cells are exposed. 
2.2 MATERIALS AND METHODS 
2.2.1 Yeast strains, media, and genetics methods 
The S. cerevisiae strains used in this study are described in Table 2.1. Growth of cells utilized 
standard media at 30°C (153). Raffinose medium contained 2% raffinose, 0.01% glucose and 
1 mg/ml antimycin A. Glycerol/ethanol medium contained a mixture of 3% (vol/vol) glycerol 
and 2% (vol/vol) ethanol. For testing inositol phenotypes, synthetic complete medium was made 
with yeast nitrogen base lacking inositol (Qbiogene, Carlsbad, CA). Strains with multiple gene 
Table 2.1 Saccharomyces cerevisiae strains used in this study. 
 
Strain Genotype 
FY1193 MATα ura3Δ52 leu2Δ1 his3Δ200 trp1Δ63 snf1Δ10 
MSY182 MATa ura3Δ52 leu2Δ1 trp1Δ63 his3Δ200 
MSY544 MATα ura3Δ52 leu2Δ1 trp1Δ63 his3Δ200 sip1Δ::HIS3 sip2Δ::HIS3 
MSY549 MATα ura3Δ52 trp1Δ63 his3Δ200 sip1Δ::HIS3 gal83Δ::HIS3 
MSY553 MATα ura3Δ52 trp1Δ63 his3Δ200 sip2Δ::HIS3 gal83Δ::HIS3 
MSY676 MATα ura3Δ0 leu2Δ0 his3Δ1 lys2Δ0 sak1Δ::KAN 
MSY683 MATα ura3Δ0 leu2Δ0 his3Δ1 lys2Δ0 tos3Δ::KAN 
MSY690 MATa ura3Δ0 leu2Δ0 his3Δ1 lys2Δ0 elm1Δ::KAN 
MSY694 MATα ura3Δ0 leu2Δ0 his3Δ1 lys2Δ0 sak1Δ::KAN tos3Δ::KAN 
MSY697 MATα ura3Δ0 leu2Δ0 his3Δ1 met15Δ0 tos3Δ::KAN elm1Δ::KAN 
MSY807 MATa ura3Δ0 leu2Δ0 his3Δ1 snf1Δ10 sak1Δ::KAN 
MSY854 MATα ura3Δ0 leu2Δ0 his3Δ1 met15Δ0 sak1Δ::KAN elm1Δ::KAN 
MSY858 MATα ura3Δ0 leu2Δ0 his3Δ1 sak1Δ::KAN tos3Δ::KAN elm1Δ::KAN 
MSY863 MATa ura3 leu2 his3 tos3Δ::KAN snf1Δ10 
MSY867 MATa ura3 leu2 his3 trp1Δ63 snf1Δ10 sak1Δ::KAN elm1Δ::KAN 
MSY870 MATα ura3 leu2 his3 lys2Δ0 snf1Δ10 tos3Δ::KAN elm1Δ::KAN 
MSY871 MATa ura3 leu2 his3 trp1Δ63 lys2Δ0 met15Δ0 snf1Δ10 elm1Δ::KAN 
MSY874 MATa ura3 leu2 his3 met15Δ0 snf1Δ10 sak1Δ::KAN tos3Δ::KAN 
MSY876 MATα ura3 leu2 his3 snf1Δ10 sak1Δ::KAN tos3Δ::KAN elm1Δ::KAN 
MSY880 MATa ura3 leu2Δ0 his3 lys2Δ0 sip1Δ::HIS3 gal83Δ::HIS3 sak1Δ::KAN 
tos3Δ::KAN 
MSY881 MATα ura3 leu2Δ0 his3 lys2Δ0 sip1Δ::HIS3 gal83Δ::HIS3 tos3Δ::KAN 
elm1Δ::KAN 
MSY882 MATa ura3 leu2Δ0 his3 sip2Δ::HIS3 gal83Δ::HIS3 sak1Δ::KAN elm1Δ::KAN 
MSY883 MATα ura3 leu2 his3 sip1Δ::HIS3 sip2Δ::HIS3 sak1Δ::KAN elm1Δ::KAN 
MSY885 MATα ura3 his3 lys2Δ0 sip1Δ::HIS3 gal83Δ::HIS3 sak1Δ::KAN elm1Δ::KAN 
MSY886 MATα ura3 leu2Δ0 his3 lys2Δ0 sip1Δ::HIS3 gal83Δ::HIS3 sak1Δ::KAN 
tos3Δ::KAN elm1Δ::KAN 
MSY888 MATa ura3 leu2Δ0 his3 lys2Δ0 met15Δ0 sip1Δ::HIS3 sip2Δ::HIS3 tos3Δ::KAN 
elm1Δ::KAN 
MSY889 MATα ura3 leu2Δ0 his3 lys2Δ0 met15Δ0 sip1Δ::HIS3 sip2Δ::HIS3 sak1Δ::KAN 
tos3Δ::KAN 
MSY890 MATα ura3 leu2Δ0 trp1Δ63 his3 met15Δ0 sip1Δ::HIS3 sip2Δ::HIS3 sak1Δ::KAN 
tos3Δ::KAN elm1Δ::KAN 
MSY891 MATα ura3 leu2Δ0 his3 met15Δ0 sip2Δ::HIS3 gal83Δ::HIS3 sak1Δ::KAN 
tos3Δ::KAN 
MSY892 MATα ura3 his3 lys2Δ0 sip2Δ::HIS3 gal83Δ::HIS3 sak1Δ::KAN tos3Δ::KAN 
elm1Δ::KAN 
MSY893 MATa ura3 leu2Δ0 his3 sip2Δ::HIS3 gal83Δ::HIS3 tos3Δ::KAN elm1Δ::KAN 
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deletions were produced by genetic crosses and sporulation. Gene deletions were confirmed by 
three primer PCR reactions that amplified different-sized products for the wild-type and null 
alleles.  
2.2.2 Epitope tagging and plasmids 
The Mig1 and Snf1 proteins were tagged with three copies of the hemagglutinin (HA) epitope at 
their C termini (129, 161) and expressed from their cognate promoters on low-copy-number 
plasmids. The Sak1, Tos3, and Elm1 proteins were all tagged with the V5 epitope (174) by 
amplifying their open reading frames and cloning them into pYES2.1 vectors (Invitrogen, UK). 
The open reading frames were then transferred by gap repair to pRS316 (171), such that 
expression was driven from each gene’s native promoter. 
2.2.3 Invertase assays 
For invertase assays, cells were grown to the mid-log phase in medium containing 2% glucose 
and collected by centrifugation. Half of the cells were used to assay invertase activity (high
glucose), and half were assayed after an additional 3 h in medium containing 0.05% glucose (low 
glucose). Quantitative invertase assays were performed as previously described (64, 162). 
2.2.4 Western blotting 
Tagged proteins were detected by Western blotting (162), using anti-HA antibodies from Santa 
Cruz Biotechnology (1:1,000 dilution) and peroxidase-conjugated sheep anti-mouse IgG 
(1:5,000) from Jackson Immuno Research Laboratories. For analysis of the phosphorylation state 
of the Snf1 threonine 210 residue, the Snf1 protein was first immunoprecipitated from cell 
extracts (500 μg protein) with anti-HA antibodies prior to Western analysis with antisera specific 
for the Snf1 protein phosphorylated on threonine 210 (129). 
2.3 RESULTS 
2.3.1 Snf phenotypes of strains lacking Snf1-activating kinases 
In order to characterize the activities of the Snf1-activating kinases, strains were constructed that 
lacked one, two, or all three of the Snf1-activating kinases, Sak1, Tos3, and Elm1 (Table 2.1). 
These strains were then tested for Snf phenotypes. Cells were grown in rich glucose media, and 
equivalent dilutions were spotted onto agar media with different carbon sources that required 
Snf1 function for growth (Figure 2.1). Strains lacking any one of these kinases were able to grow 
by fermentation of raffinose and by respiration of glycerol/ethanol, indicating that any two of the 
upstream kinases were fully capable of activating Snf1 kinase under these conditions. Strains 
expressing only one of the three Snf1-activating kinases were also tested. The sak1Δ elm1Δ, 
tos3Δ elm1Δ, and sak1Δ tos3Δ strains were able to grow on these carbon sources, indicating that 
Sak1, Tos3, and Elm1 kinases alone were able to activate sufficient Snf1 for growth under these 
conditions. Consistent with earlier reports (92, 180), strains lacking all three Snf1-activating 
kinases displayed a strong Snf- phenotype similar to that observed in snf1Δ10 cells (Figure 2.1). 
 A more quantitative measure of Snf1 kinase activity is the induction of the enzyme 
invertase in response to glucose limitation. Invertase enzyme activity was assayed from cells 
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 Figure 2.1 Growth phenotypes of Snf1-activating kinases on different carbon sources. 
Serial dilutions of yeast cultures were spotted onto rich medium with glucose (YEPD) or synthetic complete 
medium with either raffinose plus antimycin A or a mixture of glycerol and ethanol as the carbon sources. The 
relevant genotypes of the yeast strains are shown on the left. WT, wild-type. 
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grown in the presence of abundant glucose (2%) or after 3 h in limiting glucose (0.05%). Strains 
lacking Snf1 kinase or all three Snf1-activating kinases were completely unable to induce 
invertase expression when shifted to 0.05% glucose (Figure 2.2). Strains lacking any one of the 
Snf1-activating kinases were able to induce invertase in response to glucose limitation. Indeed, 
cells lacking Elm1 kinase appear to over-express invertase. Strains expressing only one of the 
Snf1-activating kinases displayed a wide range of invertase expression patterns. Cells expressing 
Tos3 as the only Snf1-activating kinase repressed invertase effectively in 2% glucose and hyper-
induced invertase when shifted to 0.05% glucose. Cells expressing Elm1 as the only Snf1-
activating kinase repressed invertase effectively and induced its expression in a similar way to 
wild-type cells. Cells expressing Sak1 as the only Snf1-activating kinase showed relatively 
normal regulation of invertase expression. Thus, Sak1, Tos3, and Elm1 are each individually 
capable of promoting proper regulation of invertase in response to glucose limitation. 
2.3.2 Mig1 phosphorylation in strains lacking Snf1-activating kinases 
The Mig1 protein is a transcriptional repressor that is known to be a direct downstream target of 
the Snf1 kinase (172, 186). Mig1 phosphorylation can be detected by Western blotting as a 
reduction in its SDS gel mobility (185). We examined the ability of cells expressing a single 
Snf1-activating kinase to phosphorylate Mig1 protein in response to glucose limitation (Figure 
2.3). As reported by Sutherland et al. (180), the phosphorylation of Mig1 is not observed in cells 
lacking Snf1 or all three of the Snf1-activating kinases (lanes 9 and 10), whereas in wild-type 
cells, Mig1 is phosphorylated when grown in low glucose (lanes 1 and 2). Cells expressing only 
 Figure 2.2 Invertase expression in Snf1-activating kinase mutants. 
Invertase expression was assayed in cells grown in 2% glucose or after shifting to 0.05% glucose for 3 h. The 
relevant genotypes of the yeast strains are shown. The mean invertase expression from three independent cultures is 
plotted. Error bars represent one standard error. mU/OD, μmole glucose/min/OD of cells assayed. 
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Figure 2.3 Phosphorylation of Mig1 by Snf1-activating kinase mutants. 
Protein extracts were prepared from cells expressing HA-tagged Mig1 after growth in the presence of high (H) or 
low (L) glucose. A Western blot (upper panel) was performed with monoclonal antibodies directed against the HA 
epitope. The mobility of Mig1 and phosphorylated Mig1 is indicated on the right. As a control for equal loading of 
protein extracts, equivalent aliquots were run in parallel and visualized by Coomassie blue staining (lower panel). 
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a single Snf1-activating kinase were capable of phosphorylating Mig1 in response to glucose 
limitation (lanes 3–8). Although the absolute level of the Mig1 protein can vary between strains, 
we conclude that each of the Snf1-activating kinases was individually capable of promoting 
Mig1 phosphorylation. 
2.3.3 Snf1-activating kinases are required for phosphorylation of the Snf1 activation loop 
Previously, we showed that Sak1 kinase is able to phosphorylate the activation loop threonine of 
Snf1 (138). Here, we show that, in the absence of Sak1, Tos3, and Elm1 kinases, the Snf1 
activation loop threonine shows absolutely no evidence of phosphorylation under low glucose 
conditions (Figure 2.4a). Therefore, Sak1, Tos3, and Elm1 are the complete complement of 
kinases that phosphorylate Snf1 threonine 210 in response to glucose limitation. We next 
examined the ability of cells lacking one or two of the Snf1-activating kinases to phosphorylate 
Snf1 threonine 210 (Figure 2.4b). All combinations of single and double mutants were able to 
phosphorylate Snf1 threonine 210 at least to some level in response to glucose limitation. 
However, some differences were observed. Most notably, the elm1Δ cells and the elm1Δ tos3Δ 
cells exhibited higher levels of threonine 210 phosphorylation under high glucose conditions 
(lanes 7 and 13). This finding is consistent with the higher levels of invertase expression 
observed in these cells in the presence of high glucose (Figure 2.2). 
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Figure 2.4 Phosphorylation of Snf1 threonine 210 requires Snf1-activating kinases. 
Snf1 protein was immunoprecipitated with HA antibody from protein extracts of cells grown in either high (H) or 
low (L) glucose. Precipitates were analyzed by Western blotting using either anti-HA antibodies (α-HA) or 
antibodies specific for the Snf1 protein phosphorylated on threonine 210 (α-PT210). A Wild-type cells (lanes 1-4) 
or sak1Δ tos3Δ elm1Δ cells (lanes 5 and 6) were transformed with a plasmid expressing Snf1-HA (lanes 3-6) or an 
empty vector (lanes 1 and 2). A light and dark exposure of the α-PT210 Western is shown. B Wild-type cells (lanes 
1 and 2) and cells lacking one or two of the Snf1-activating kinases (lanes 3-14) were transformed with a plasmid 
expressing Snf1-HA and analyzed as above. 
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2.3.4 β subunits of Snf1 kinase complexes confer strong upstream kinase preferences 
Yeast strains were constructed such that they expressed a single β subunit in combination with a 
single upstream kinase. Each strain was tested for invertase expression under high- and low-
glucose conditions (Figure 2.5). Cells expressing Sip1 as the only β subunit in combination with 
all three upstream kinases or with Sak1 or Tos3 showed relatively normal invertase regulation. 
However, the combination of Sip1 and Elm1 was much less effective at inducing invertase. 
When Sip2 was the only β subunit, only Sak1 kinase was able to induce invertase expression. 
The combinations of Sip2 with Tos3 or Elm1 were completely ineffective at invertase induction. 
When Gal83 was the only β subunit, a clear preference for Sak1 was observed, although Tos3 
and Elm1 were individually able to function at a reduced level. We conclude that the β subunits 
do indeed confer upstream kinase specificity, although the situation is more complex than a 
simple one-to-one correspondence of upstream kinase to Snf1 complex isoform. 
2.3.5 Snf1-activating kinase preference is stress-dependent 
Cells expressing a single β subunit and a single upstream kinase were assayed for growth under 
conditions that required the Snf1 kinase. We tested growth by fermentation of raffinose, by 
respiration of a mixture of glycerol and ethanol, and by fermentation of glucose in the absence of 
inositol. The absence of inositol promotes transcriptional induction (derepression) of the INO1 
gene, a process which requires Snf1 kinase (167). Cells expressing Sip1 as their only β subunit 
were able to ferment raffinose in combination with either Sak1 or Tos3 but not Elm1 as the 
upstream kinase (Figure 2.6). As reported by Schmidt and McCartney (161), cells expressing 
  
Figure 2.5 Invertase expression in cells expressing a single isoform of Snf1 kinase. 
Invertase expression was assayed in cells grown in 2% glucose or after shifting to 0.05% glucose for 3 h. The 
genotypes of the yeast strains at the SAK1, TOS3, and ELM1 loci are shown below, and the genotypes at the SIP1, 
SIP2, and GAL83 loci are indicated above. The mean invertase expression from three independent cultures is 
plotted. Error bars represent one standard error. 
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Figure 2.6 Growth phenotypes of cells expressing a single β subunit and Snf1-activating kinase. 
Serial dilutions of yeast cultures were spotted onto synthetic complete medium lacking uracil, either with glucose 
(Glu), raffinose plus antimycin A (Raf), or a mixture of glycerol and ethanol as the carbon sources (GE), or with 
glucose as the carbon source and without inositol (-Ino). The relevant genotypes of the yeast strains are shown on 
the left. Each strain was transformed with a CEN URA3 plasmid containing either no insert (vector) or the complete 
gene for the indicated Snf1-activating kinase. 
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Sip1 as the only β subunit were not able to grow aerobically and further deletion of upstream 
kinases did not suppress this growth defect. Sak1 and Elm1 but not Tos3 supported growth in the 
absence of inositol. Thus, the Sip1 isoform of the Snf1 kinase displays strong stress-dependent 
preferences for its upstream activating kinase. Cells expressing Sip2 as the only β subunit were 
able to ferment raffinose only when Sak1 was present. The combination of Sip2 with Tos3 or 
with Elm1 was not functional for growth on raffinose, and little or no invertase induction was 
observed in these cells (Figures 2.5 and 2.6). A different result was observed when cells were 
assayed for aerobic growth or for growth in the absence of inositol. Under those stresses, any one 
of the upstream kinases was sufficient for activation of the Sip2 isoform of Snf1 kinase. Finally, 
when Gal83 was the only β subunit, any one of the upstream kinases was able to provide Snf1 
activation for growth on raffinose, although Sak1 was clearly the most efficient. Any one of the 
upstream kinases was able to activate the Gal83 isoform of Snf1 for growth on glycerol/ethanol 
or in the absence of inositol. We conclude that different isoforms of the Snf1 kinase display 
stress-dependent preferences for the Snf1-activating kinases. 
2.3.6 Snf1-activating kinase expression in cells expressing different Snf1 isoforms 
Different isoforms of Snf1 kinase are poorly activated by some of the upstream kinases. One 
explanation for this could be that the upstream kinases are poorly expressed or fail to accumulate 
in some mutant backgrounds. To determine whether deletion of genes encoding the Snf1 kinase 
β subunits might affect the abundance of the upstream kinases, we measured the abundance of 
the upstream kinases by Western blotting (Figure 2.7). Strains were constructed in which all 
three genes for the upstream kinases were deleted (sak1Δ tos3Δ elm1Δ). In addition, cells 
expressed either all three β subunits of the Snf1 kinase (denoted as WT) or only a single 
  
 
Figure 2.7 Accumulation of upstream kinases in cells expressing different isoforms of the Snf1 kinase. 
A Strains with all three upstream kinases deleted (sak1Δ tos3Δ elm1Δ) were transformed with CEN plasmids 
expressing a single V5-tagged upstream kinase, as indicated on the right. In addition, cells contained genes either for 
all three β subunits (WT) or for a single β subunit, as indicated at the top of each lane. Protein extracts were 
prepared from cells grown in either high (H) or low (L) glucose. Tagged proteins from 500 μg extract were collected 
with anti-V5 antibodies. B Tos3-V5 mobility shift is due to Snf1-dependent phosphorylation. Tos3-V5 protein was 
expressed in cells containing (lanes 1 and 2) or lacking (lanes 3 and 4) Snf1. Protein extracts were incubated at 37°C 
for 1 h with (lanes 2 and 4) or without (lanes 1 and 3) 5 units of calf intestine alkaline phosphatase (CIP). Samples 
were analyzed by Western blotting with anti-V5 antibodies. 
  39
  40
β subunit (shown above each lane). The upstream kinases tagged with the V5 epitope were 
expressed from their own promoters on low-copy-number plasmids and their abundance was 
measured by Western blotting. In all cases, equivalent aliquots were run in parallel and stained 
by Coomassie blue to verify that comparable protein levels were present in each sample (data not 
shown). Sak1 and Elm1 were both expressed at equivalent levels, regardless of the isoform of 
Snf1 present and independent of the glucose concentration. Tos3 kinase was present in all cell 
types at equivalent levels, but was found in both high- and low-mobility forms. The slower-
migrating form is due to phosphorylation since it could be shifted to the faster-migrating species 
by treatment with phosphatase (Figure 2.4b, lane 2). The phosphorylation is Snf1-dependent, 
since it is not observed in snf1Δ10 cells (lane 3). We conclude that the failure of some pairings of 
upstream kinases with certain isoforms of Snf1 kinase to function is not due to any problems 
with upstream kinase expression. For instance, the Sip2 isoform of Snf1 kinase was unable to 
induce invertase when Elm1 was the only upstream kinase present (Figure 2.5). This defect is not 
due to a failure to express Elm1 kinase (Figure 2.7a, lane 7). 
2.3.7 Activation loop phosphorylation in strains expressing Sip2 as the only β subunit 
Since the Sip2 isoform of Snf1 kinase exhibited the most stringent preference for Sak1 under 
low-glucose conditions, we tested whether the Snf1 activation loop threonine was 
phosphorylated in the Sip2 isoform of the enzyme in the presence of each of the upstream 
kinases. Cells expressing Sip2 as the only β subunit and either no upstream kinases or only a 
single upstream kinase were grown in the presence of high glucose (2%), low glucose (0.05%), 
or a non-fermentable carbon source (a mixture of glycerol and ethanol, GE). Snf1 protein was 
immunoprecipitated, and the level of phosphorylation on threonine 210 was assayed by Western 
  
Figure 2.8 Phosphorylation of the Snf1 activation loop in cells expressing the Sip2 isoform of the Snf1 kinase. 
Proteins were immunoprecipitated with anti-HA antibody from protein extracts of cells grown in either high glucose 
(H), low glucose (L), or a mixture of glycerol and ethanol (GE). Precipitates were analyzed by Western blotting, 
using either anti-HA antibodies (α-HA) or antibodies specific for the Snf1 protein phosphorylated on threonine 210 
(α-PT210). A single yeast strain (MSY886) was used in this experiment, and its relevant genotype is shown. Cells 
were transformed with a CEN plasmid with either no insert (vector; lanes 1-3) or full-length copies of the SAK1 
(lanes 4-6), TOS3 (lanes 7-9), or ELM1 (lanes 10-12) genes. 
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blot (Figure 2.8). In the absence of any upstream kinase (lanes 1–3), phosphorylation of 
threonine 210 was not detected under any growth condition. A Western blot against the HA 
epitope present at the C-terminus of the Snf1 protein indicated that equivalent levels of Snf1 
were present in all the immunoprecipitates. When Sak1 was the only upstream kinase, the Sip2 
isoform of Snf1 showed robust phosphorylation of threonine 210 when cells were grown on low 
glucose or a non-fermentable carbon source (lanes 5 and 6) but not when grown on high glucose 
(lane 4). When Tos3 (lanes 7–9) or Elm1 (lanes 10–12) was the only upstream kinase present, 
phosphorylation of threonine 210 was also detected, although the levels appeared lower than that 
observed with Sak1. We conclude that any one of the three upstream kinases is able to 
phosphorylate the Sip2 isoform of Snf1 kinase on threonine 210 in response to carbon source 
stress.  
2.3.8 Mig1 phosphorylation in strains expressing Sip2 as the only β subunit 
In growth and invertase assays that measured Snf1 activity, the Sip2 isoform of the Snf1 kinase 
displayed a distinct preference for the Sak1 kinase, and yet Tos3 and Elm1 were also able to 
phosphorylate Snf1 on threonine 210. Therefore, we next examined downstream signaling of the 
Sip2 isoform of Snf1. The phosphorylation state of the Mig1 protein in cells expressing Sip2 as 
the only β subunit was examined by Western blot (Figure 2.9). Hypo-phosphorylated Mig1 
protein was detected in all cells examined when glucose was present at high concentrations 
(lanes 1, 4, 7, 10, 13). When shifted to low glucose, the hyper-phosphorylated form of Mig1 was 
detected in cells expressing all three upstream kinases (lane 2) or Sak1 only (lane 8). The Mig1 
phosphorylation was completely dependent on the three Snf1-activating kinases, since no 
phosphorylation of Mig1 was observed when all three Snf1-activating kinases were deleted
  
Figure 2.9 Mig1 phosphorylation in cells expressing only the Sip2 isoform of the Snf1 kinase. 
Cells were transformed with a plasmid expressing HA-tagged Mig1 protein. Protein extracts were prepared from 
cells grown in synthetic complete medium containing either 2% glucose (H) or 3 h after shifting to 0.05% glucose 
(L) or glycerol/ethanol (GE), as indicated. Mig1 protein was detected with anti-HA antibodies. As a control for 
equal loading of protein, a gel run in parallel was stained with Coomassie blue and photographed (Stain). All strains 
in this experiment expressed the Sip2 protein as the only Snf1 kinase β subunit (sip1Δ gal83Δ). The different 
combinations of deletions in the Snf1-activating kinases are indicated. 
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(lanes 13–15). Interestingly, when Tos3 or Elm1 were the only upstream kinases present, 
significant levels of the hypo-phosphorylated Mig1 were detected in low glucose (lanes 5 and 
11). This failure to effectively phosphorylate Mig1 in cells with only Sip2 and Tos3 or only Sip2 
and Elm1 correlated with the poor growth properties of these cells on raffinose media (Figure 
2.6) and with their inability to induce invertase expression (Figure 2.5). We also looked at the 
phosphorylation state of Mig1 after cells were shifted to a non-fermentable carbon source for 3 h. 
Cells expressing Elm1 as the only upstream kinase displayed increased ability to phosphorylate 
Mig1 relative to the low-glucose-grown cells (lanes 5 and 6), consistent with the observation that 
cells expressing only Sip2 and Elm1 were able to grow aerobically (Figure 2.6). The 
combination of Sip2 and Tos3 showed the lowest levels of Mig1 phosphorylation under both 
Snf1-activating conditions tested (lanes 11 and 12), and yet Tos3 was able to promote activation 
loop phosphorylation of the Sip2 isoform of Snf1 (Figure 2.7). These results suggest that 
additional levels of regulation of Snf1 kinase signaling must occur downstream of the activation 
loop phosphorylation step. 
2.4 DISCUSSION 
The underlying hypothesis being tested is that each of the three Snf1-activating kinases is 
dedicated to the activation of a single isoform of the Snf1 kinase. The data presented here and in 
an earlier report (84) disprove this very simplistic hypothesis. For instance, the Sak1 kinase is 
able to activate all three isoforms of the Snf1 kinase in response to low glucose, as judged by 
growth assays on raffinose (Figure 2.6) and invertase induction (Figure 2.5). Therefore, Sak1 is 
not dedicated to the activation of a single isoform of the Snf1 kinase. A similar conclusion was 
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reached by Hedbacker et al. (84). The converse of our hypothesis, that the three Snf1-activating 
kinases are promiscuous and equally capable of activating all three isoforms of the Snf1 kinase is 
also not supported by our data. For instance, the Sip2 isoform of the Snf1 enzyme was poorly 
activated if at all by Tos3 or Elm1 in response to low glucose, as judged by invertase induction 
and growth assays on raffinose (Figures 2.5 and 2.6). Therefore, the Sip2 isoform of Snf1 kinase 
exhibited a strong preference for the Sak1 kinase under low glucose conditions. Interestingly, the 
Sip2 isoform of the Snf1 kinase expanded its activating kinase preference to include Sak1, Tos3, 
and Elm1 during growth on ethanol or in the absence of inositol (Figure 2.6). Therefore, the 
upstream kinase preference was stress-dependent. We conclude that the dedicated activator 
hypothesis and its converse, the promiscuous activator hypothesis, are not valid. Our data 
support an intermediate model in which different isoforms of the Snf1 kinase do in fact exhibit 
strong and distinct preferences for specific Snf1-activating kinases and the preference varies, 
depending on both the β subunit identity and the stress response. 
Yeast cells adapt to changes in glucose concentrations with both short-term and long-
term changes in patterns of gene expression (56, 91). In this study, the invertase expression and 
the Mig1 and Snf1 protein phosphorylation states were measured 2–3 h after shifting to low 
glucose and are thus measurements of short-term responses. In contrast, the ability of cells to 
ferment raffinose or respire a mixture of glycerol and ethanol was assessed after several days of 
growth and reflect long-term responses. We noted a strong correlation between invertase 
induction, a short-term response and growth on raffinose, a long-term response. For instance, 
cells with Sip2 as the only Snf1 β subunit were able to induce invertase only in combination with 
Sak1 as the Snf1-activating kinase (Figure 2.5). Similarly, the combination of Sip2 with Sak1 
showed much better growth on raffinose than the pairing of Sip2 with Tos3 or Elm1 (Figure 2.6). 
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Similar correlations were observed in Sip1 cells, where invertase induction with Sak1 and Tos3 
also correlated well with growth on raffinose.  
The observed preferences by the isoforms of Snf1 for the different upstream kinases 
might be explained by differences in subcellular localization. Studies using green fluorescent 
protein (GFP)-tagged proteins showed that Snf1, Snf4, and the β subunits are localized to distinct 
compartments (97, 194) and that their localization is dynamic, changing in response to the 
carbon source (85, 194). The localization of the upstream kinases is less well defined. Elm1 
kinase displays a very restricted localization, limited to the bud neck (20, 97, 132). None of the 
Snf1 subunits have ever been found to be concentrated at this location. The localization of Tos3 
has not been defined, since GFP fusion to Tos3 was not detected (97). The Sak1-GFP expressed 
from its genomic locus exhibits a cytosolic localization in high glucose (84). In low glucose, 
some of the Sak1-GFP fluorescence shifts to the outer vacuolar membrane. A similar shift is 
observed for Sip1 (85). Our data are consistent with the idea that the incompatibility of particular 
pairs of Snf1 isoforms and upstream kinases may be explained by differences in subcellular 
localization.  
However, differences in the subcellular localization of Snf1 and its activating kinase 
cannot account for all of our observations. For instance, we found that the pairing of the Sip2 
isoform of Snf1 with Tos3 kinase did not reconstitute efficient Snf1 signaling in response to low 
glucose (Figures 2.5 and 2.6). Yet, Tos3 phosphorylated the activation loop threonine of Snf1 
when Sip2 was the only β subunit present (Figure 2.8). Since Tos3 was able to phosphorylate the 
activation loop threonine, the Snf1 and Tos3 proteins must co-localize at least transiently. The 
defect in Snf1 signaling appears to be downstream of the activation loop phosphorylation, since 
the Mig1 protein was not efficiently phosphorylated in response to low glucose in cells 
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expressing only Sip2 and Tos3 (Figure 2.9). It is important to note that, although we are able to 
detect activation loop phosphorylation, we are not able to assess what fraction of the total Snf1 
pool is phosphorylated, nor can we determine from what subcellular compartment the activated 
Snf1 originates. The fact that Mig1 is poorly phosphorylated by the Sip2 isoform of Snf1 despite 
the fact that some fraction of the Snf1 is phosphorylated on threonine 210 may indicate that the 
activated Snf1 and Mig1 are not present in the same compartment. Alternatively, the Snf4-
mediated activation step may be defective in cells expressing only Tos3 and Sip2.  
Global studies of protein expression levels suggest that there are far fewer Snf1 
molecules than β and γ subunits (71). All evidence for Snf1 kinase stoichiometry, including 
silver-stained gels of purified Snf1 complexes (137), suggests that the three subunits are 
associate in a 1:1:1 stoichiometry. Therefore, the three β subunits, possibly pre-bound to the 
abundant γ subunit (Snf4), must compete for binding to the far fewer molecules of Snf1. Of all 
the β subunits, the Sip2 protein may well be the most affected by a model in which Snf1 
signaling is controlled by competitive binding to a limiting number of Snf1 proteins. Global 
expression analyses of the Snf1 kinase subunits did not detect any large changes in mRNA 
abundance for Snf1, Snf4, Sip1, or Gal83 in response to changes in carbon source. In contrast, 
microarray analysis of mRNA levels in response to glucose limitation (213) and growth on 
ethanol (66) detected large increases in the Sip2 message. Increased abundance of Sip2 protein in 
cells shifted to a non-fermentable carbon source was also shown by Western blots of a GFP-Sip2 
fusion protein (194). In light of a model in which Snf1 signaling is defined by competition 
between paralogous proteins, we predict that increased levels of Sip2 protein leads to a greater 
proportion of Snf1 kinases complexes containing the Sip2 protein, leading to greater signaling 
through the Sip2 isoform of the Snf1 kinase complex. If Snf1 signaling pathways are defined in 
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part by competitive binding of subunits to the kinase, then caution is needed when interpreting 
studies which utilize gene deletions (such as this study). The absence of competing subunits 
would promote the association of the remaining subunits and affect the signaling pathways under 
investigation.  
Finally, we ask which of the three Snf1-activating kinases activates Snf1 in vivo. The data 
presented here suggests that all three kinases play a role in Snf1 activation, depending on the 
stress and the β subunit identity. However, we must also consider the possibility that one (or 
two) of these kinases is the predominant activator(s) of Snf1 in vivo and that the other kinase(s) 
participates in Snf1 activation only when the cognate activator(s) is missing. Two lines of 
evidence suggest that Sak1 is the predominant activator of Snf1 in vivo. First, Sak1 is the most 
promiscuous, since it was able to activate all three isoforms of the Snf1 kinase complex under all 
stress conditions tested. Second, mass spectrometric experiments of proteins associated with 
Snf1 identified Sak1 but not Tos3 or Elm1 (68, 89). In addition, there is good reason to believe 
that Elm1 kinase participates in other signaling pathways, probably by activating the Snf1-
related kinases, Hsl1, Kcc4, and Gin4 (20, 133, 182). Further experiments using techniques more 
subtle than gene deletions will be needed to determine whether Sak1 is the primary activator of 
Snf1 in vivo. 
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 3.1 INTRODUCTION 
The serine/threonine protein kinase Snf1 in Saccharomyces cerevisiae and its mammalian 
orthologue, the AMP-activated protein kinase (AMPK), are central mediators of nutrient stress 
response. Members of this family are found in all eukaryotic organisms (77). When activated, 
these kinases conserve cellular energy by promoting processes that generate cellular ATP while 
inhibiting those that consume ATP (204). Interest in the AMPK signaling pathway has increased 
since the discovery that AMPK is activated by metformin, the most widely prescribed 
therapeutic used to treat type II diabetes (201). Understanding the molecular mechanisms that 
regulate this signaling pathway could lead to the discovery of new targets for the treatment of 
type II diabetes. 
In yeast, many of the downstream signaling events of the Snf1 pathway are well 
understood. In contrast, the regulation of events upstream of Snf1 is just beginning to be 
elucidated. Activation of Snf1 requires the phosphorylation of threonine 210 in the Snf1 
activation loop (60) by a distinct upstream kinase (129). Recently, we identified Sak1 as a Snf1-
activating kinase (138). Sak1 associates with Snf1 and is capable of phosphorylating the 
activation loop threonine of Snf1 in vivo and in vitro (54, 138). However, Sak1 is not the only 
Snf1-activating kinase in yeast. In addition, two closely related kinases, Tos3 and Elm1, share 
this function with Sak1 (92, 180). Sak1, Tos3, and Elm1 exhibit the most similarity in the 300-
residue kinase domain. Nonconserved N-terminal and C-terminal domains represent half of the 
protein for Tos3 and even more for Elm1 and Sak1. The three Snf1-activating kinases are not 
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functionally interchangeable but exhibit some specialization in function (84, 128). Since the N- 
and C-terminal domains are the most divergent, we hypothesized that these domains may define 
their different functional capacities. 
SAK1 was first identified as a high-copy-number suppressor of temperature-sensitive 
DNA polymerase α mutations and was originally designated PAK1 for Polymerase Alpha Kinase 
(95). Subsequently, the term PAK has become widely used to refer to p21-activated kinases, a 
family of serine/threonine protein kinases that are regulated by small GTP-binding proteins. 
Yeast genes encode members of the PAK family (Ste20, Cla4, and Skm1), but the yeast PAK1 
product is not a member of the p21-activated kinase family. Thus, to avoid further confusion, the 
yeast PAK1 gene (YER129W) has been renamed SAK1, for Snf1-Activating Kinase (54). The 
Saccharomyces Genome Database has agreed to this name change. 
Many protein kinases are regulated at least in part by the phosphorylation of one or more 
residues in their respective activation loops (141). This paradigm holds true for the Snf1 kinase. 
However, Sak1, Tos3, and Elm1 lack a conserved threonine residue in their activation loops, 
suggesting that the Snf1-activating kinases may be regulated by other means. Indeed, recent 
studies of LKB1, a functional mammalian orthologue of the Snf1-activating kinases, indicate that 
the phosphorylation of the LKB1 activation loop plays no role in its activation (19). Instead, 
LKB1 is activated by the binding of two accessory proteins, Mo25 and STRAD. Some kinases 
that do not require activation loop phosphorylation contain extensions of the activation loop or 
insertions elsewhere in the kinase domain. For instance, casein kinase 1 has an unusually long 
activation loop, and phosphorylase kinase has an insertion of a sequence that contacts and 
stabilizes the activation loop (141). The C terminus of the yeast Sky1 kinase interacts with the 
activation loop, holding the kinase in a constitutively active conformation (142). The 
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mechanisms that regulate the Snf1-activating kinases are not known. In this study, we examine 
the role(s) the N- and C-terminal nonkinase domains play in the regulation and function of the 
Snf1-activating kinases. 
3.2 MATERIALS AND METHODS 
3.2.1 Yeast strains and media 
Yeast strains used in this study were MSY857 (MATα ura3Δ0 leu2Δ0 his3Δ1 met15Δ0 
sak1Δ::KAN elm1Δ::KAN tos3Δ::KAN) and MSY876 (MATα ura3 leu2 his3 sak1Δ::KAN 
elm1Δ::KAN tos3Δ::KAN snf1Δ10). Yeast was grown at 30°C in standard media (153). Glucose 
was present at 2% or 0.05% (g/100 ml), as indicated in the relevant figures. The glycerol-ethanol 
medium contained a mixture of glycerol at 3% (vol/vol) and ethanol at 2% (vol/vol). The 
raffinose medium contained 2% (g/100 ml) raffinose, 0.05% (g/100 ml) glucose, and antimycin 
A (1 μg/ml). 
3.2.2 Plasmids 
Plasmids used in this study were generated using gap repair and standard subcloning protocols. 
Plasmids used in this study and their salient features are presented in Table 3.1. All Snf1-
activating kinases were tagged with one or five copies of the V5 epitope at their C termini. 
Protein deletion constructs are summarized in Table 3.2. 
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Table 3.1 Plasmids used in this study. 
 
Plasmid or 
Plasmid Type 
Kinase expressed Promoter Epitopea Marker Replicon 
pSnf1HA-315 SNF1 SNF1 3x HA LEU2 CEN 
High-copy number SAK1 or ELM1 ADH1 V5 URA3 2 μm 
Low-copy number SAK1, TOS3, or ELM1 Cognate 5x V5 URA3 CEN 
 
a 3x or 5x, 3 or 5 tandem copies of the indicated epitope. 
 
 
Table 3.2 Protein deletion constructs. 
 
Kinase AAs presentb AAs deleted 
Sak1 1-1142  
Sak1ΔC 1-500 511-1142 
Sak1ΔN 1, 130-1142 2-129 
Sak1ΔNΔC 1, 130-500 2-129, 501-1142 
Sak1ΔN1 1, 2, 87-1142 3-86 
Sak1ΔN2 1-86, 130-1142 87-129 
Sak1ΔMc 1-573, 628-1142 574-627 
Tos3 1-560  
Tos3ΔC 1-350 351-560 
Tos3ΔM 1-345, 399-560 346-398 
Elm1 1-640  
Elm1ΔC 1-420 421-640 
 
b AA, amino acid. 
c ΔM, deletion of the conserved motif. 
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3.2.3 Protein extraction 
Cultures of yeast cells (25 to 50 ml) were harvested in mid-log phase (optical density at 600 nm, 
0.4 to 0.8), and protein extracts were prepared by vortexing them with glass beads in 
radioimmunoprecipitation assay buffer (50 mM Tris HCl [pH 8], 150 mM NaCl, 0.1% sodium 
dodecyl sulfate [SDS], 1% NP-40, 0.5% deoxycholate) with protease inhibitors (100 μg/ml 
phenylmethylsulfonyl fluoride, 2 μg/ml leupeptin, 2 μg/ml aprotinin, 2 μg/ml pepstatin, and 2 
μg/ml chymostatin) and phosphatase inhibitors (50 mM NaF and 5 mM NaPPi). For analysis of 
Snf1 activation loop threonine phosphorylation, cells were harvested following the addition of 
NaOH to 0.1 M, suspended in SDS sample buffer (62 mM Tris-Cl [pH 6.8], 10% glycerol, 5% β-
mercaptoethanol, 3% SDS), and subjected to overnight dialysis against 2 liters of 
radioimmunoprecipitation buffer. Protein concentrations were determined using the Bradford 
method (21) with bovine serum albumin as a standard. 
3.2.4 Western blotting 
Horseradish peroxidase-conjugated mouse monoclonal antibodies (Santa Cruz Biotechnology, 
Santa Cruz, CA) against the hemagglutinin (HA) epitope were used to detect HA-tagged Snf1. 
Rabbit polyclonal antibodies directed against phosphorylated Snf1 threonine 210 (129) were 
used to detect phosphorylated Snf1. Horseradish peroxidase-conjugated mouse monoclonal 
antibodies (Invitrogen, Carlsbad, CA) against the V5 epitope were used to detect Sak1, Tos3, and 
Elm1 variants that were epitope-tagged with V5. 
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3.2.5 Invertase assays 
Invertase activity of log-phase cells grown in high- or low-glucose medium was quantitatively 
assayed using a colorimetric assay coupled to glucose oxidase (162). Three independent cultures 
were assayed, and the mean values are shown in the relevant figures. 
3.2.6 Immune complex kinase assays 
Cultures of yeast cells (50 ml) were harvested in mid-log phase (optical density at 600 nm, 0.4 to 
0.8), and protein extracts were prepared by vortexing with glass beads in ice-cold lysis buffer (20 
mM Tris-HCl [pH 7.2], 12.5 mM potassium acetate, 4 mM MgCl2, 0.5 mM EDTA, 0.1% Tween 
20, 12.5% glycerol, and 1 mM dithiothreitol) with protease inhibitors (2 μg/ml leupeptin, 2 
μg/ml pepstatin, 1 mM benzamidine, 2 μg/ml aprotinin, 2 μg/ml pepstatin A, 2 μg/ml 
chymostatin, and 1 mM phenylmethylsulfonyl fluoride). Extracts were precleared by incubation 
with 20 μl 50% protein A-Sepharose beads (Sigma) at 4°C for 30 min. All protein A-Sepharose 
beads were prewashed twice with lysis buffer. V5-tagged Sak1 lacking the N and C termini 
(Sak1ΔNΔC) was immunoprecipitated from 200 μg protein with 0.75 μl anti-V5 antibody 
(Invitrogen) and 15 μl 50% protein A-conjugated beads at 4°C for 2 h. Immune complexes were 
collected by centrifugation, washed once with lysis buffer and twice with kinase assay buffer (20 
mM HEPES [pH 7.0], 0.5 mM EDTA, 0.5 mM dithiothreitol, and 5 mM Mg acetate), and 
suspended in kinase buffer (20 μl final volume) containing 0.2 mM [γ-32P]ATP (500 cpm/pmole) 
and the glutathione S-transferase (GST)-Snf1 kinase domain at approximately 50 μg/ml. Proteins 
were eluted from the beads by incubation in SDS sample buffer at 95°C for 5 min. Labeled 
proteins were resolved on an SDS-polyacrylamide gel and subjected to autoradiography. 
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3.2.7 Microscopy 
Differential interference contrast images of yeast cells were collected with a Nikon 2000e 
microscope using a 1.45-numerical-aperture, 60× objective, a q-imaging Retiga EXI cooled 
charge-coupled-device camera, and Metamorph software. 
3.3 RESULTS 
3.3.1 Carboxy termini of Sak1 and Tos3 are required for efficient Snf1 pathway signaling 
The locations of the kinase domains in the three Snf1-activating kinases (Sak1, Tos3, and Elm1) 
are displayed in Figure 3.1a. All three Snf1-activating kinases contain large C-terminal domains 
that share little homology outside of a small conserved motif found in Sak1 and Tos3 but not 
Elm1 (Figure 3.1a and b). We investigated whether this conserved motif or the entire carboxy-
terminal domains of Sak1, Tos3, and Elm1 are required for Snf1 signaling. Cells lacking all three 
Snf1-activating kinases were transformed with low-copy-number plasmids expressing full-length 
or truncated versions of the Snf1-activating kinases. Tables 3.1 and 3.2 describe in more detail 
the plasmids and deletion constructs used in these studies. The truncated versions of Sak1, Tos3, 
and Elm1 were all stably expressed at comparable levels, as judged by Western blotting (Figure 
3.1d). In the absence of all three Snf1-activating kinases, cells are unable to grow by 
fermentation of raffinose or by respiration of glycerol and ethanol (Figure 3.1c). Cells expressing 
full-length Sak1, Tos3, or Elm1 all recover the ability to grow on these alternative carbon 
sources, demonstrating that any one of the Snf1-activating kinases is sufficient to promote Snf1 
  
Figure 3.1 C-terminal-deletion mutants of the Snf1-activating kinases. 
A Schematic representation of the Elm1, Tos3, and Sak1 kinases drawn to scale. The positions of the kinase 
domains (KD) and a conserved motif (open box) are indicated. B Sequence alignment of the conserved motif found 
in the C-terminal domains of Sak1 and Tos3 kinases from S. cerevisiae and of Sak1 homologues from Ashbya 
gossypii (Ag; GenBank accession no. AAS51175), Kluyveromyces Lactis (Kl; GenBank accession no. XP_453478), 
Candida glabrata (Cg; GenBank accession no. XP_448319), and Candida Albicans (Ca; GenBank accession no. 
EAK98348). C Serial dilutions of yeast cultures were spotted onto agar plates with glucose (Glu), raffinose (Raf), or 
a mixture of glycerol and ethanol (GE) as the carbon sources. Cells lacked all three Snf1-activating kinases but were 
transformed with low-copy-number plasmids expressing no kinase (vector), full-length kinase, a C-terminal 
truncation (ΔC), or a precise deletion of the conserved motif found in Sak1 and Tos3 (ΔM). D Western blot of V5-
tagged Snf1-activating kinases. Protein extracts of the cells shown in panel C were prepared from cultures grown in 
high (H) glucose (2%) or after shifting to low (0.05%) glucose (L). Snf1-activating kinases were all tagged with five 
copies of the V5 epitope at the C terminus of each protein and were expressed from their cognate promoters on low-
copy-number plasmids. WT, wild-type. 
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signaling. Deletion of the entire C-terminal domains from these kinases had no effect on their 
ability to grow by fermentation of raffinose. However, aerobic growth was markedly reduced in 
cells expressing Sak1ΔC or Tos3ΔC as the sole Snf1-activating kinase. Of the three C-terminal 
deletion constructs examined, the Tos3ΔC construct showed the most severe reduction in growth 
on glycerol-ethanol. In contrast, the Elm1ΔC construct appeared fully functional in these growth 
assays, suggesting that the Elm1 C terminus is not needed for its participation in the Snf1 
signaling pathway. Deletion of the conserved motif found in Sak1 and Tos3 had no effect on the 
ability of cells to ferment raffinose but affected aerobic growth. Tos3 lacking the conserved 
motif displayed a 10-fold reduction in this spot dilution assay. While deletion of the conserved 
motif did impair functions, especially for Tos3, we conclude that the conserved motif is not 
essential for Sak1 or Tos3 participation in Snf1 signaling. Likewise, the entire C-terminal 
domains of Sak1 and Tos3 appear to be important but not entirely essential for Snf1 signaling. In 
contrast, the Elm1 C-terminal domain is entirely dispensable for growth on alternative carbon 
sources. 
 Invertase expression provides a more quantitative means by which to measure Snf1 
signaling and thereby the function of these carboxy-terminal-truncation variants of the Snf1-
activating kinases. When present as the only Snf1-activating kinase, either Sak1ΔC or Tos3ΔC 
was able to induce invertase, although less efficiently than the corresponding full-length proteins 
(Figure 3.2). Consistent with the growth phenotypes shown in Figure 3.1, the deletion of the C 
terminus had the largest effect on Tos3 function and the least effect on Elm1 function. Deletion 
of the conserved motif present in Sak1 and Tos3 had a small but detectable effect on invertase 
induction. We conclude that the conserved motif plays only a minor role in Snf1-mediated 
invertase induction. The C-terminal domains of Sak1, Tos3, and Elm1 are not absolutely 
  
Figure 3.2 Invertase expression in cells with Sak1, Tos3, and Elm1 mutations. 
Invertase activity was assayed with cells grown in 2% glucose (Glu) or after shifting to 0.05% glucose for 3 h. Cells 
lacked all three Snf1-activating kinases but were transformed with low-copy-number plasmids expressing either no 
kinase (Vec), full-length kinase, a C-terminal truncation (ΔC), or a precise deletion of the conserved motif (ΔM). 
The mean invertase activity level for three independent transformants is plotted. Error bars represent one standard 
error. mU/OD, μmole glucose/min/OD of cells assayed. 
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required for Snf1 function; however, those of Sak1 and Tos3 are needed for efficient Snf1 
signaling. 
3.3.2 The Elm1 carboxy terminus is required for normal morphology maintenance 
The carboxy terminus of Elm1 is not required for efficient activation of the Snf1 signaling 
pathway (Figure 3.1c and 3.2). Indeed, by analysis of growth assays (Figure 3.1c), Elm1ΔC 
activates Snf1 as well as full-length Elm1 does. Because Elm1 is also required for the 
morphogenetic checkpoint (17), we examined the morphology of cells expressing wild-type 
Elm1 or Elm1ΔC. Cells lacking Sak1, Tos3, and Elm1 display elongated morphologies, and the 
cells are bunched together in clusters, a phenotype typically observed when ELM1 is absent 
(Figure 3.3, row 1). A low-copy-number plasmid (CEN) encoding full-length Elm1 rescues cells 
from this abnormal morphology (Figure 3.3, row 2), while a low-copy-number plasmid 
expressing Elm1ΔC does not (Figure 3.3, row 3). Therefore, the carboxy terminus of Elm1 is 
required to specify its role in morphology maintenance. Intriguingly, however, when Elm1ΔC is 
present at a high copy number, normal morphology is restored (Figure 3.3, row 4), suggesting 
that the increased abundance of the kinase activity of Elm1 can compensate for the loss of its C 
terminus. 
3.3.3 The Sak1 amino terminus is required for Snf1 signaling 
Having established that the carboxy termini of Sak1 and Tos3 are required for efficient function 
in the Snf1 pathway, we next wished to assess what roles the amino termini might play in 
glucose signaling. Because Sak1 appears to be the primary Snf1-activating kinase (54, 84, 128), 
  
Figure 3.3 Cell morphology of elm1Δ mutants. 
Cell morphology was analyzed by differential interference contrast microscopy. Cells lacked all three Snf1-
activating kinases but were transformed with either low-copy-number (CEN) or high-copy-number (2μm) plasmids 
expressing no kinase (vector), full-length Elm1 kinase (ELM1), or a C-terminal truncation of the Elm1 kinase 
(ELM1ΔC). Bar, 1 μm. 
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we focused our attention on Sak1. We therefore engineered Sak1 constructs lacking only the 
amino terminus or both the amino- and carboxy-terminal domains (Sak1ΔN and Sak1ΔNΔC, 
respectively) and examined their abilities to activate Snf1 in response to glucose limitation. Cells 
expressing Sak1ΔN or Sak1ΔNΔC as the only Snf1-activating kinase are unable to grow on 
raffinose or glycerol-ethanol media (Figure 3.4a). Similarly, Sak1 constructs lacking their N 
termini are unable to induce invertase expression (Figure 3.4b). All constructs were stably 
expressed at comparable levels, as judged by Western blotting (Figure 3.4c). Thus, while the 
carboxy terminus of Sak1 is necessary for efficient transduction of Sak1-to-Snf1 signaling, the 
amino terminus is absolutely obligatory for Snf1 signaling outputs. 
3.3.4 The Sak1 kinase domain is active in vivo and in vitro. 
The deletion of the Sak1 N terminus completely blocks its ability to promote Snf1 signaling. One 
simple explanation for this would be that deletion of amino acids 2 to 129 inactivates the Sak1 
kinase activity. This possibility was tested directly by immune complex kinase assays. The V5-
tagged Sak1ΔNΔC protein was overexpressed and collected from yeast extracts with agarose 
beads conjugated with anti-V5 antibodies. Immune complexes were incubated with [γ-32P]ATP 
and a recombinant substrate, the GST-Snf1 kinase domain, that has been used in previous studies 
(54). Sak1ΔNΔC protein promotes phosphorylation of the GST-Snf1 kinase domain (Figure 3.5a, 
lane 3). The reaction is specific for the activation loop of the Snf1 kinase domain since a single 
amino acid mutation in the substrate (threonine 210 to alanine) completely blocks the reaction 
(Figure 3.5a, lane 4). Equivalent levels of Sak1ΔNΔC protein were present in the reactions, as 
judged by Western blotting of immune complexes run in parallel (Figure 3.5b). We conclude that
  
Figure 3.4 Growth phenotypes and invertase expression in cells lacking the N or C terminus of Sak1. 
Cells lacking all three Snf1-activating kinases were transformed with low-copy-number plasmids expressing no 
kinase (vector), full-length Sak1 kinase, Sak1ΔN, Sak1ΔC, or Sak1ΔNΔC. A Serial dilutions of yeast cultures were 
spotted onto agar plates with glucose (Glu), raffinose (Raf), or a mixture of glycerol and ethanol (GE) as the carbon 
sources. B Invertase activity was assayed in cells grown in 2% glucose (Glu) or after shifting to 0.05% glucose for 3 
h. The mean invertase activity level for three independent transformants is plotted. Error bars represent one standard 
error. C Western blot of V5-tagged Sak1 proteins. Protein extracts were prepared from cells grown in high glucose 
(H) or after 3 h in low glucose (L). Each construct contained five copies of the V5 epitope at its C terminus. vec, 
plasmid vector. mU/OD, μmole glucose/min/OD of cells assayed. 
  64
  
Figure 3.5 The Sak1 kinase domain is catalytically active. 
A In vitro kinase assay. A snf1Δ sak1Δ tos3Δ elm1Δ yeast strain was transformed with a high-copy-number plasmid 
expressing V5-tagged Sak1ΔNΔC protein or with plasmid vector (Vec). Sak1ΔNΔC protein was immunoprecipitated 
with anti-V5 epitope beads and incubated with [γ-32P]ATP either alone or with recombinant substrates purified from 
bacteria. The substrates tested were the GST-Snf1 kinase domain (lanes 1 and 3) and the GST-Snf1 kinase domain 
with the T210A mutation (lane 4). Labeled proteins were resolved on an SDS-polyacrylamide gel and detected by 
autoradiography. B Western blot of immunoprecipitated Sak1ΔNΔC. Protein extracts were immunoprecipitated as 
described for panel A and probed with anti-V5 antibody to detect levels of Sak1ΔNΔC protein. C A strain lacking 
all three Snf1-activating kinases (sak1Δ tos3Δ elm1Δ) was transformed with high-copy-number plasmids expressing 
no kinase (vector), full-length Sak1, or Sak1ΔNΔC. Serial dilutions of yeast cultures were spotted onto agar plates 
with glucose (Glu), raffinose (Raf), or a mixture of glycerol and ethanol (GE) as the carbon sources. 
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the Sak1 kinase domain is catalytically active and specific, despite the deletion of its N- and C-
terminal domains. 
Since the Sak1 kinase domain is active, we tested whether overexpression of the Sak1 
kinase domain could activate Snf1 signaling. The Sak1 kinase domain (Sak1ΔNΔC) was 
overexpressed from the strong, constitutive ADH1 promoter on a high-copy-number plasmid and 
assayed for its ability to activate Snf1 kinase. Serial dilutions of liquid cultures were spotted onto 
solid media containing glucose, raffinose, or a mixture of glycerol and ethanol as the carbon 
source. In spot dilution growth assays, we have found that aerobic growth requires a higher level 
of Snf1 signaling than does growth by fermentation of raffinose. Cells overexpressing full-length 
Sak1 were able to grow on raffinose and glycerol-ethanol, indicating robust Snf1 signaling 
(Figure 3.5c). In contrast, overexpression of the Sak1 kinase domain (Sak1ΔNΔC) provides a 
lesser degree of Snf1 signaling that is sufficient for fermentation of raffinose but not for efficient 
aerobic growth. Therefore, the Sak1 kinase domain is catalytically active in vivo but is partially 
defective. A similar result was obtained with Elm1, where deletion of the C terminus caused an 
impairment in the Elm1 signaling that could be suppressed by overexpression (Figure 3.3). 
3.3.5 Localization of critical residues in the amino terminus of Sak1 
Since the amino terminus of Sak1 is required for Sak1 function (Figure 3.4), we sought to 
identify the N-terminal residues critical for Sak1 function. Alignment of the N termini of the 
Snf1-activating kinases from S. cerevisiae with the N termini of homologous kinases from other 
fungal species identified two regions of partial sequence conservation (Figure 3.6). These two 
regions of conservation were deleted individually in two additional constructs and tested for their 
ability to promote Snf1 signaling. To accomplish this, Snf1 signaling outputs (invertase 
  
Figure 3.6 Multiple sequence alignment of the N termini of the Snf1-activating kinases with fungal homologues. 
The N termini of Snf1-activating kinases from S. cerevisiae (Sak1, Tos3, and Elm1) are aligned with the N termini 
of homologous proteins. Abbreviations and GenBank accession numbers of the other fungal sequences are given in 
the legend to Figure 3.1b. The demarcations between N1 and N2 and between N2 and the kinase domains are 
indicated. The yeast cyclin-dependent kinase Cdc28 lacks any N-terminal extension and is included in order to show 
the boundary of the conserved serine/threonine kinase domain. 
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induction and growth on alternative carbon sources) were assayed with cells expressing 
Sak1ΔN1 (lacking residues 3 to 86) or Sak1ΔN2 (lacking residues 87 to 129) as the only Snf1-
activating kinase. When Sak1ΔN1 was expressed, the cells functioned normally by fermentation 
of raffinose and respiration of glycerol and ethanol (Figure 3.7a) and induced invertase in low 
glucose (Figure 3.7b). In contrast, Sak1ΔN2 failed to function in the Snf1 pathway, as 
demonstrated by the failure to induce invertase (Figure 3.7b) or to promote growth on raffinose 
or glycerol and ethanol (Figure 3.7a). All of the N-terminal-deletion constructs were expressed at 
equivalent levels in vivo, as judged by Western blotting (Figure 3.7c). We conclude that Sak1 
residues 87 to 129 are essential for Sak1 function in vivo. 
3.3.6 Effect of N- and C-terminal deletions on Sak1’s ability to phosphorylate the Snf1 
activation loop 
Upon glucose limitation, Sak1, Tos3, and Elm1 activate Snf1 by phosphorylation of threonine 
210 (T210) in the activation loop (92, 180). We wished to determine which of the Sak1 
constructs developed for this study resulted in Snf1 T210 phosphorylation. Snf1-HA and the 
Sak1 variants were coexpressed in strains lacking the genomic copies of all three Snf1-activating 
kinases. Because these analyses are carried out in strains expressing Sak1 as the only upstream 
kinase, any observed phosphorylation of Snf1 can be confidently attributed to Sak1. Extracts 
were prepared from cells grown in high or low glucose. Snf1 was immunoprecipitated and 
probed for phosphorylation on threonine 210 by antibodies specific for the phosphorylated 
activation loop threonine (129). When glucose is limiting, Snf1 threonine 210 is phosphorylated 
in cells expressing full-length Sak1 (Figure 3.8a, lanes 1 and 2). When the carboxy terminus of 
  
Figure 3.7 Identification of critical residues in the Sak1 amino terminus. 
Cells lacking all three Snf1-activating kinases were transformed with a low-copy-number plasmid expressing an 
empty vector (vector), full-length Sak1, or Sak1 mutants lacking the entire N terminus (ΔN), the first half of the N 
terminus (ΔN1), or the second half of the N terminus (ΔN2). A Serial dilutions of liquid cultures were spotted onto 
media with glucose (Glu), raffinose (Raf), or a mixture of glycerol and ethanol (GE) as the carbon source. B 
Invertase activity was assayed in cells grown in 2% glucose or after shifting to 0.05% glucose for 3 h. The mean 
invertase activity level for three independent transformants is plotted. Error bars represent one standard error. 
mU/OD, μmole glucose/min/OD of cells assayed. C Western blot of V5-tagged Sak1 proteins. Extracts prepared 
from cells grown in high glucose (H) or after 3 h in low glucose (L) were analyzed directly by Western analysis with 
anti-V5 antibodies. 
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Figure 3.8 Snf1 activation loop phosphorylation in Sak1 mutant strains. 
Cells lacking all three Snf1-activating kinases were cotransformed with two low-copy-number plasmids expressing 
Snf1-HA and full-length Sak1 or deletion mutants of Sak1, as indicated in the legend to Figure 3.4. Protein extracts 
were prepared from cells grown in medium containing high glucose (H) or after 3 h in low glucose (L). Snf1-HA 
was immunoprecipitated with anti-HA antibody and probed by Western blotting with antibodies directed against 
Snf1 phosphorylated on threonine 210 (α-PT210). Equivalent aliquots (20 μg) of each extract were also analyzed 
directly by Western analysis with anti-HA antibodies (α-HA). 
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Sak1 is deleted, Snf1 is still phosphorylated exclusively in low glucose, though the level of T210 
phosphorylation is greatly reduced (lanes 3 and 4). Deletion of the N terminus of Sak1 
completely blocks Snf1 phosphorylation in either high or low glucose (lanes 5 and 6). Similarly, 
in cells expressing the Sak1 kinase domain alone (Sak1ΔNΔC), Snf1 is not phosphorylated under 
either condition tested (lanes 7 and 8). Interestingly, this same construct was able to specifically 
phosphorylate the activation loop of Snf1 in vitro (Figure 3.5). This analysis was extended to 
include the smaller deletions within the Sak1 N terminus. Deletion of the first half of the N 
terminus (N1) did not adversely affect the ability of Sak1 to phosphorylate the activation loop 
threonine of Snf1, while deletion of the second half of the N terminus (N2) completely blocked 
the ability of Sak1 to phosphorylate the activation loop of Snf1 (Figure 3.8b). Equivalent levels 
of Snf1 protein are expressed in all the samples, as judged by Western blotting with anti-HA 
antibody (Figure 3.8, lower panels). We conclude that the ability of the Sak1 kinase domain to 
phosphorylate the activation loop of Snf1 in vivo requires regulatory domains in addition to its 
kinase domain. 
3.4 DISCUSSION 
The Snf1-activating kinases of S. cerevisiae contain conserved kinase domains as well as large 
domains that contain only limited sequence conservation (Figure 3.1a). In this report, we 
investigated whether these N-terminal and C-terminal domains of the Snf1-activating kinases are 
required for their biological function in vivo. Our results indicate that the C-terminal domains 
play an important role in determining pathway specificity. Deletion of the C termini of Sak1 and 
Tos3 greatly reduced their ability to activate Snf1 signaling. C-terminal deletions of Sak1 and 
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Tos3 showed impaired aerobic growth (Figure 3.1c), impaired invertase induction (Figure 3.2), 
and, in the case of Sak1, impaired phosphorylation of the Snf1 activation loop (Figure 3.8). All 
these results imply that the C termini of Sak1 and Tos3 are needed for efficient signaling in the 
Snf1 pathway. In contrast, deletion of the C terminus of Elm1 had no effect on aerobic growth, 
had only a modest effect on invertase induction, and caused a complete abrogation of its ability 
to function in the morphogenetic-checkpoint signaling pathway. Thus, the C termini of Sak1 and 
Tos3 direct them to the Snf1 pathway, while the C terminus of Elm1 directs it to a different 
signaling pathway. 
In a screen to identify yeast proteins that phosphorylate mammalian AMPK in vitro, 
Sutherland et al. identified a carboxy-truncated Elm1 similar to what we have here designated 
Elm1ΔC (180). In that study, the truncated Elm1 variant activated Snf1 more robustly than did 
full-length Elm1 but was unable to complement an elm1Δ strain's morphological defect unless 
Snf1 was also deleted. These data support the notion that the C-terminal domains play an 
important role in pathway participation. Pathway selection could be specified by subcellular 
localization or various affinities for components of the signaling pathways in which the kinase 
participates. It is possible that full-length Elm1 might have a higher affinity for morphology 
signaling components than for Snf1, whereas Elm1ΔC associates better with Snf1 than with 
proteins at the bud neck. This may explain why a high-copy-number but not a low-copy-number 
plasmid expressing Elm1ΔC rescues cells from the elongated-morphology characteristic of 
elm1Δ mutants (Figure 3.3). The Tos3 protein kinase is localized in the cytoplasm in high and 
low glucose (108), while Sak1 appears to be localized in the cytoplasm in high glucose and at the 
vacuolar periphery in low glucose (84). Whether the C-terminal domains of Sak1 and Tos3 
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specify signaling through Snf1 by controlling its localization or its association with other 
proteins remains to be determined. 
Finally, we identified a small region in the N terminus of Sak1 that is absolutely required 
for participation in the Snf1 signaling pathway. When Sak1 is expressed at normal levels, the 
deletion of amino acids 87 to 129 of Sak1 completely blocks its ability to activate Snf1, as 
judged by growth assays (Figure 3.7a), invertase induction (Figure 3.7b), and Snf1 activation 
loop phosphorylation (Figure 3.8b). A small domain of Sak1 included in the N2 deletion 
(residues 110 to 129) is conserved with other homologous fungal kinases, including Tos3, but 
not with Elm1. This region is not required for the catalytic activity of Sak1 since a construct 
consisting solely of the Sak1 kinase domain (residues 130 to 500) is catalytically active in vitro 
and in vivo (Figure 3.5). Therefore, this small domain of Sak1 must play some critical regulatory 
role that remains to be elucidated by further studies. 
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 4.1 INTRODUCTION 
The Snf1 protein kinase of Saccharomyces cerevisiae is a founding member of a family of 
protein kinases that includes the mammalian AMP-activated protein kinase (AMPK) (77) and is 
present in all eukaryotes. Interest in this family has been increased by the finding that the 
medications used to treat type 2 diabetes activate AMPK (80). Indeed, the metabolic 
consequences of AMPK activation, which include increased glucose uptake and oxidation, 
increased fatty acid oxidation, inhibition of anabolic reactions, and stimulation of reactions that 
regenerate ATP (208), are beneficial to patients experiencing hyperglycemia. With the rise in the 
prevalence of obesity and type 2 diabetes in Western cultures, a more complete understanding of 
the mechanisms that regulate the activity of the AMPK/Snf1 enzymes is needed. 
The AMPK/Snf1 enzymes function as heterotrimers with a catalytic α subunit associated 
with regulatory β and γ subunits. The α subunit contains a canonical kinase domain in its N 
terminus and an autoinhibitory domain in its C terminus (40). The catalytic activities of the 
AMPK/Snf1 enzymes are regulated in a complex manner. First, subunit interactions within the 
AMPK/Snf1 heterotrimer regulate enzymatic activity in response to the cellular energy status. 
Although not all agree on the mechanism, the γ subunit appears to play an important role in the 
regulation of AMPK/Snf1 catalytic activity. The mammalian γ subunit can bind AMP (165) and 
can interact with the α subunit autoinhibitory domain to abrogate its inhibitory potential (40, 
103). An alternative but not necessarily exclusive model posits the presence of a pseudosubstrate 
sequence in the γ subunit (165). Second, AMPK/Snf1 kinases require phosphorylation of a 
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conserved threonine residue in their activation loops by a distinct upstream kinase (60, 79, 129). 
Concerted effort by several research groups led to the identification of the activating kinases for 
Snf1 and AMPK (78, 92, 138, 180, 203). Yeasts encode three Snf1-activating kinases (SAKs), 
Sak1, Tos3, and Elm1 (92, 138, 180), and all three SAKs must be deleted to block Snf1 
signaling. In mammalian cells, LKB1 is the primary activating kinase of AMPK under conditions 
of energy stress (119, 203), although other kinases may contribute to AMPK activation in 
specific cell types or in response to other stimuli (81, 98, 131, 202). 
It was hoped that the identification of the activating kinases for Snf1 and AMPK would 
rapidly lead to an understanding of the means by which cellular energy status controlled the 
activity of the AMPK/Snf1 pathway. However, several lines of evidence suggest that the 
AMPK/Snf1-activating kinases are not themselves regulated by energy status. First, LKB1, the 
primary activator of AMPK (78, 203), is the activation loop kinase for at least 12 other kinases 
that are responsive to different stimuli (119). If LKB1 were in fact regulated by cellular energy 
status, one would predict increased activity toward all of its substrates under conditions of 
nutrient limitation. This is not observed. Furthermore, when LKB1 was expressed in yeast in 
place of the SAKs, Snf1 activation loop phosphorylation responded normally to changes in 
glucose levels (93). Either LKB1 could sense energy status in both yeast and mammalian cells or 
the phosphorylation status of the Snf1 activation loop was not regulated at the level of phosphate 
addition. Third, reactions with purified components showed that the addition of AMP did not 
stimulate LKB1-mediated phosphorylation of AMPK but rather inhibited its dephosphorylation 
(159, 179). Fourth, mutations in the γ subunit of AMPK affect the ability of the PP2C 
phosphatase to dephosphorylate the AMPK activation loop (159). Finally, one of the three SAKs, 
Elm1, is required for normal cell morphology (20, 177). Cells lacking Elm1 display the 
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characteristic elongated morphology for which Elm1 was named. Since yeast cells display 
normal morphology in both glucose-rich and glucose-limited media, the Elm1 kinase must be 
active in both growth conditions. However, the Snf1 kinase activation loop shows a much greater 
degree of phosphorylation when cells are grown in limiting glucose conditions (129). The fact 
that Snf1 is not phosphorylated in glucose-rich media even when Elm1 is active suggests that the 
phosphorylation status of the Snf1 activation loop might not be regulated by phosphate addition, 
but rather by dephosphorylation. All of these data taken together suggest that the 
dephosphorylation reaction may be the regulated step in determining the phosphorylation status 
of the AMPK/Snf1 activation loop. 
Genetic studies have long indicated that the dephosphorylation of the Snf1 activation loop 
was mediated by the yeast PP1 protein phosphatase Glc7 (188). Deletion of the GLC7 gene is 
lethal, thus complicating study of the PP1 phosphatase in yeast. Glc7 can bind to several 
alternative regulatory subunits that are thought to direct the phosphatase to different substrates 
(205). The accessory subunit that directs Glc7 to the Snf1 signaling pathway is Reg1 (187). 
Deletion of the REG1 gene results in constitutive activation of Snf1 and hyper-phosphorylation 
of its activation loop (129). Models for the AMPK/Snf1 pathway in which dephosphorylation is 
the key to regulation have been lacking, perhaps because the laboratories studying AMPK and 
Snf1 (ours included) tend to have a kinase-centric worldview. The experiments in this report are 
designed to directly test whether the SAKs, the deactivating phosphatase, or both are regulated 
by glucose. 
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4.2 MATERIALS AND METHODS 
4.2.1 Yeast strains and media 
Strains used in this study are presented in Table 4.1. Yeast were grown at 30°C in standard 
media. Glucose was present at 2 or 0.05% (g/100 ml), as indicated in the relevant figure legends. 
Raffinose medium contained 2% (g/100 ml) raffinose, 0.05% (g/100 ml) glucose, and 1 µg/ml 
antimycin A. In order to create a complete deletion of the REG1 gene, a reg1Δ::HIS3 allele was 
created using the HIS3 gene from pRS403 (1622-bp SspI fragment) flanked by the sequences 
from the REG1 locus. The upstream sequences from REG1 were the 824-bp EcoRI-BsaAI 
fragment representing nucleotides –953 to –129 relative to the REG1 ATG codon. The 
downstream sequences from REG1 were the 237-bp BsaAI-XbaI fragment representing 
sequences 143–380 downstream from the REG1 stop codon. REG1 gene replacement was 
confirmed by PCR. 
4.2.2 Plasmids and mutagenesis 
All Snf1-activating kinases were expressed from their own cognate promoters, tagged with five 
copies of the V5 epitope at the C terminus, and introduced to cells on low-copy plasmids based 
on pRS315 (171). Point mutations in the ATP-binding pockets of Sak1, Tos3, and Elm1 were 
introduced with the Stratagene QuikChange site-directed mutagenesis kit (Stratagene, La Jolla, 
CA). TAP-tagged versions of the three SAKs have been described previously (54). A low-copy 
plasmid expressing the Mig1 protein tagged with the HA epitope at the C terminus has been 
previously described (161). 
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Table 4.1 Saccharomyces cerevisiae strains used in this study. 
 
Strain Genotype 
FY1193 MATa ura3Δ52 leu2∆1 trp1∆63 his3∆200 snf1∆10 
MSY857 MATa ura3∆0 leu2∆0 his3∆1 met15∆0 sak1∆::KAN tos3∆::KAN elm1∆::KAN 
MSY923 MATa ura3 leu2 his3 sak1∆::KAN tos3∆::KAN elm1∆::KAN snf1∆10 
MSY951 MATa ura3 leu2 his3 sak1∆::KAN tos3∆::KAN elm1∆::KAN SNF1-3HA  
MSY955 MATa ura3Δ52 leu2∆1 his3∆200 SNF1-3HA  
MSY956 MATa ura3 leu2 trp1∆63 his3 lys2∆0 sak1∆::KAN tos3∆::KAN SNF1-3HA 
MSY958 MATa ura3 leu2 trp1∆63 his3 sak1∆::KAN elm1∆::KAN SNF1-3HA 
MSY961 MATa ura3 leu2 his3 tos3∆::KAN elm1∆::KAN SNF1-3HA 
MSY963 MATa ura3Δ52 leu2∆1 his3∆200 trp1∆63 SNF1-3HA reg1∆::HIS3 
MSY964 MATa ura3 leu2 trp1∆63 his3 lys2∆0 sak1∆::KAN tos3∆::KAN SNF1-HA 
reg1∆::HIS3 
MSY965 MATa ura3 leu2 trp1∆63 his3 sak1∆::KAN elm1∆::KAN SNF1-3HA reg1∆::HIS3 
MSY966 MATa ura3 leu2 his3 sak1∆::KAN tos3∆::KAN elm1∆::KAN SNF1-3HA 
reg1∆::HIS3 
MSY983 MATa ura3 leu2 his3 tos3∆::KAN elm1∆::KAN SNF1-3HA reg1∆::HIS3 
MSY987 MATa ura3Δ52 leu2∆1 trp1∆63 his3∆200 snf1∆10 reg1∆::HIS3 
 
4.2.3 Screen for altered-sensitivity alleles 
Overnight saturated yeast cultures (200 µl) grown at 30°C were suspended in 3 ml of 47°C top 
agar (containing 0.07% (g/100 ml) Bacto Agar, synthetic complete media lacking uracil with 2% 
(g/100 ml) sucrose, 1 µg/ml antimycin A, and 0.01% (g/100 ml) glucose). The mixture was 
carefully mixed and poured onto agar plates containing synthetic complete media lacking uracil 
with 2% (g/100 ml) sucrose, 0.01% (g/100 ml) glucose, and 1 µg/ml antimycin A. The top agar 
mixture was allowed to cool and harden. Sterile filter discs were gently placed on the surface of 
the top agar. 3 µl of 2.5 or 25 µM candidate inhibitor drugs (in DMSO) were applied to the filter 
discs. DMSO alone was used as a negative control. Plates were incubated at 30°C overnight and 
  79
photographed. The design and use of the altered sensitivity allele of Snf1 will be described in 
detail elsewhere (168). 
4.2.4 Invertase assays 
Invertase activity of midlog cells grown in high and low glucose was determined quantitatively 
using a colorimetric assay coupled to glucose oxidase (72). Three independent cultures were 
assayed, and the mean and standard error values are plotted. The units of invertase activity used 
were milliunits/OD where one unit equals 1 µmole of glucose released/min.  
4.2.5 Western blotting 
Protein extracts were prepared using the NaOH cell lysis method as described previously (129). 
To detect Snf1 activation loop threonine 210 (T210) phosphorylation, 600–1200 µg of protein 
was immunoprecipitated in radioimmunoprecipitation buffer as previously described (129). 
Rabbit polyclonal antibody directed against phosphorylated Snf1 T210 was used as the primary 
antibody (1:1000) to detect phosphorylated Snf1. Horseradish peroxidase-conjugated goat anti-
rabbit antibody was used as secondary antibody (1:15,000) (Santa Cruz Biotechnology, Santa 
Cruz, CA). For Snf1-HA detection, 20–40 µg of protein extract was used. Snf1-HA was detected 
by a horseradish peroxidase-conjugated antibody (1:1000) recognizing the HA epitope (Santa 
Cruz Biotechnology). 
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4.2.6 Immune complex kinase assay 
Protein extracts were prepared from cells expressing a single SAK as a C-terminal TAP fusion 
(54) or without any SAK. SAKs were collected from 300 µg of protein extract by 
immunoprecipitation with IgG beads. Precipitates were washed five times in 
radioimmunoprecipitation buffer and two times in kinase assay buffer as described (54). 
Precipitates were then incubated in 20 µl of kinase assay buffer with 0.2 mM [γ-32P]ATP (1000 
cpm/pmole) and purified recombinant Snf1 kinase domain as the substrate. Reactions were 
incubated for 1 h at 30°C and then subjected to SDS-PAGE and autoradiography. 
4.3 RESULTS 
4.3.1 Snf1-activating kinases are active in high and low glucose 
If the phosphorylation status of the Snf1 activation loop were regulated by phosphate addition, 
then one would predict that the SAKs would be inactive in high glucose and activated by low 
glucose. We have described above several lines of evidence that suggest the opposite, that the 
SAKs may be active in both high and low glucose. Three different experiments were conducted 
to assess whether glucose regulates the activity of one or more of the SAKs. First, we measured 
invertase activity in cells expressing a single SAK with and without the PP1 regulatory subunit 
Reg1. When Reg1 is absent, Snf1-dependent invertase expression is elevated in both high and 
low glucose (187), and the Snf1 activation loop becomes phosphorylated in high glucose (129). 
Consistent with prior observations, strains expressing Reg1 and all three SAKs exhibit normal, 
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glucose-regulated invertase induction (Figure 4.1). In the absence of Reg1, cells with all three 
SAKs display elevated invertase activity independent of glucose, indicating that one or more of 
the SAKs is active in high glucose. In the absence of all three SAKs, invertase activity is minimal 
regardless of the glucose concentration or the presence or absence of Reg1, confirming previous 
work indicating that Sak1, Tos3, and Elm1 represent the complete complement of SAKs (92, 
180). In order to determine if any of the SAKs were responsive to changes in glucose levels, 
Sak1, Tos3, and Elm1 were each expressed as the only SAK in the presence and absence of 
Reg1. In the absence of Reg1, invertase is elevated in both high and low glucose regardless of 
which SAK is present (Figure 4.1), indicating that each of the three SAKs is capable of activating 
Snf1 in high glucose. When Reg1 is present, glucose regulation of invertase activity is restored. 
These results support the idea that the SAKs are active regardless of the glucose concentration. 
Earlier work has suggested that Sak1 is the primary SAK. Of the three SAKs, only Sak1 
is found in stable complex with Snf1 (54). Sak1 most efficiently activates all three β subunit-
specific isoforms of Snf1 under multiple conditions (128) and is the only SAK that can promote 
nuclear localization of the Gal83 isoform of Snf1 (84). Consistent with these data, Sak1 most 
robustly induces invertase activity, particularly in the absence of Reg1 (Figure 4.1). The reduced 
induction of invertase in cells expressing Elm1 as the only SAK may be a reflection of 
sequestration of Elm1 at the bud-neck for its role in regulating cell cycle and morphogenesis (20). 
A second measure of SAK activity is the measurement of activation loop phosphorylation 
using a phosphopeptide antibody specific for Snf1 phosphorylation on the activation loop 
threonine 210 (PT210) (129). In this experiment, cells were grown in high glucose in the 
presence or absence of Reg1, protein extracts were prepared, and total Snf1 and T210 
phosphorylation were determined by Western blotting with either HA antibodies (Figure 4.2, 
  
Figure 4.1 Snf1-activating kinases are active in high and low glucose. 
Invertase activity was measured in cells containing all three, none, or only one of the SAKs in the presence or 
absence of REG1 as indicated. Aliquots were assayed from cells grown in high glucose (2%) or after shifting to low 
glucose (0.05%) for 2 h. The mean value from three independent cultures is plotted with the error bars indicating 
one standard error. 
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bottom) or PT210 antibodies (top), respectively. In multiple independent experiments, the 
presence or absence of Reg1 affected the phosphorylation status of the Snf1 activation loop but 
did not affect the level of total Snf1 protein. Results from a representative experiment are shown 
in Figure 4.2. In wild-type cells, phosphorylation of the Snf1 activation loop is regulated in 
response to changes in glucose levels (lanes 1 and 2). In high glucose, cells expressing all three 
SAKs show low but detectable T210 phosphorylation when Reg1 is present and distinctly 
elevated phosphorylation when Reg1 is absent (lanes 3 and 4). In the absence of all three SAKs, 
no phosphorylation of T210 is detected, regardless of whether Reg1 is present or not (lanes 5 and 
6). When the SAKs are expressed individually, the level of T210 phosphorylation is increased by 
the absence of Reg1, regardless of which SAK is present (lanes 7–12). Some variation is 
observed between the individual SAKs. Sak1 and Elm1 show higher basal phosphorylation (lanes 
7 and 11) compared with Tos3 (lane 9). Nonetheless, the conclusion we reach is that the SAKs 
are capable of phosphorylating Snf1 in high glucose, supporting the idea that the SAKs are active 
in both high and low glucose conditions. However, these two experiments do not exclude the 
possibility that the Glc7-Reg1 complex regulates the SAKs. Therefore, our next experiment was 
designed to measure SAK activity without disrupting the Glc7-Reg1 complex. 
Previously, we have used the tandem affinity purification protocol to isolate the three 
SAKs, Sak1, Tos3, and Elm1 (54). In that study, we also showed that the Sak1 complex 
constituents and activity were not affected by carbon source (glucose versus sucrose). The 
activity of Tos3 and Elm1 prepared from different carbon sources was not measured. In the third 
experiment to measure the activity of the SAKs, we conducted in vitro kinase assays with each 
SAK isolated from cells grown in high glucose or 2 h after a shift to low glucose. The SAKs 
were collected by immunoprecipitation and assayed for the ability to phosphorylate purified 
  
Figure 4.2 Phosphorylation of the Snf1 kinase activation loop in reg1Δ cells. 
Western blot of Snf1 protein using antibodies directed against the phosphorylated form of the Snf1 activation loop 
(αPT210) or against the HA epitope. Cells expressing all three, one, or none of the SAKs (as shown) were grown in 
high (H) or low (L) glucose. Cells contained the wild-type REG1 gene (+) or a complete deletion of the REG1 (Δ) as 
indicated. 
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recombinant Snf1 kinase domain (Figure 4.3). In earlier experiments, we have shown that the 
SAKs phosphorylate the Snf1 kinase domain exclusively on threonine 210 (54). In order to be 
certain that we were in the linear range of the assay, immune complexes were collected from 
increasing quantities of extract (0–300 µg). The reaction depended on exogenous substrate, since 
no incorporation was observed when recombinant Snf1 kinase domain was omitted from the 
reaction. For each SAK, a similar level of activity was observed in reactions using extracts 
prepared from cells grown in high and low glucose. The first three experiments described here all 
support the idea that the SAKs are active in both high and low glucose. Since the 
phosphorylation status of the Snf1 activation loop is regulated by glucose, the simplest model 
remaining is that the dephosphorylation of Snf1 is regulated by glucose. 
4.3.2 Identification of an altered-sensitivity allele of TOS3 
To monitor the rate of Snf1 activation loop dephosphorylation, we sought to develop a means to 
rapidly and selectively inactivate the SAKs. In the absence of de novo phosphate addition, 
changes in Snf1 phosphorylation status may be attributed to the phosphatase, enabling us to 
determine if the activity of Glc7-Reg1 is regulated by changes in glucose concentration. A 
chemical genetic method has been developed for specifically inactivating protein kinases (16). 
By changing the "gatekeeper" residue in the ATP-binding pocket from a bulky hydrophobic 
residue to glycine or alanine, kinases can be engineered that are selectively inhibited by adenine 
analogues. An analogue-sensitive variant of the SAK Elm1 (threonine 200 mutated to glycine) 
has been reported (176). Because the primary role of Elm1 seems not to be Snf1 activation but 
rather participation in cell morphology signaling, we sought to identify analogue-sensitive alleles 
of the other SAKs, Sak1 and Tos3, whose only described role is activation of Snf1. 
  
Figure 4.3 Activity of Snf1-activating kinases is independent of glucose. 
In vitro kinase assays were performed with SAKs immunoprecipitated from protein extracts of cells grown in either 
high or low glucose. Cells expressed a single, TAP-tagged SAK (as shown). Precipitates were incubated in the 
presence of [γ-32P]ATP with (+) or without (-) the addition of recombinant Snf1 kinase domain (Snf1-KD) as a 
substrate. Activity present in a titration from 0 to 300 μg of protein extract is shown. 
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 The gatekeeper residues of Sak1 (leucine 223) and Tos3 (leucine 135) were changed to 
glycine and alanine. Plasmids encoding these kinase variants were introduced to cells that lacked 
the genes for all three SAKs. A library of adenine analogues was screened for the ability to block 
Snf1 signaling in cells expressing analogue-sensitive variants of the SAKs without affecting 
signaling in cells expressing the wild-type kinase. All attempts to identify a specific inhibitor for 
the altered sensitivity alleles of Sak1 were unsuccessful. However, we were successful with 
Tos3, using the Tos3-L135G allele in combination with the adenine analogue CZ22 (Figure 4.4). 
In a screen to identify specific inhibitors for our mutant kinases, cells were grown as a lawn with 
sucrose as the carbon source and antimycin A to prevent aerobic metabolism. Under these 
conditions, Snf1 signaling is required for growth. Adenine analogues suspended in DMSO were 
spotted onto filter discs. Formation of a halo around the disc was indicative of compromised Snf1 
signaling, an outcome expected when the only SAK present in cells is inhibited. When cells were 
exposed to CZ22, a halo of growth inhibition was observed when Tos3-L135G was the only 
SAK. No halo was observed with cells expressing wild-type Tos3 (Figure 4.4a). Therefore, the 
growth inhibition by CZ22 is specific to the sensitized allele of TOS3. 
In order to determine the effective concentration of CZ22, induction of the enzyme 
invertase was measured in cells grown in high glucose and shifted to low glucose as an indicator 
of Snf1 activation by Tos3-L135G or wild-type Tos3 (Figure 4.4b). Cells expressing the wild-
type or sensitized Tos3 kinase as the only SAK were initially grown in glucose-rich media. CZ22 
was included in the media at the shift to low glucose at concentrations of 0 (DMSO only), 1, 2.5, 
or 25 µM. In the absence of CZ22, cells expressing either the wild-type Tos3 or the sensitized 
Tos3-L135G show robust invertase induction upon shifting to low glucose, indicating that the 
Tos3-L135G allele is fully functional. When CZ22 is included in the reactions at 1 and 2.5 µM, 
  
Figure 4.4 Analogue-sensitive allele of the Snf1-activating kinase Tos3. 
A Cells expressing either Tos3 or Tos3-L135G as the only SAK were mixed with top agar and overlaid onto a plate 
containing sucrose as the carbon source. Sterile discs were spotted with either DMSO or the adenosine analogue 
CZ22 dissolved in DMSO. B Invertase assay. Cells expressing either the wild-type Tos3 or the analogue-sensitive 
Tos3-L135G as the only SAK were assayed for invertase induction after growth in high glucose (H) or following 2 h 
of incubation in media containing 0.05% glucose (L). The adenosine analogue CZ22 was added to the final 
concentration indicated. Mean values of invertase activity from three independent cultures are plotted with the error 
bars signifying one standard error. C CZ22 blocks Snf1 activation loop phosphorylation. Cells expressing Tos3-
L135G as the only SAK were grown in high glucose (H) or shifted to low glucose (L) in the presence of added 
DMSO or 2.5μM CZ22 dissolved in DMSO. Total and activated Snf1 protein was assessed by Western blotting with 
anti-HA antibodies (α-HA) or the phosphopeptide antibody specific for the phosphorylated activation loop of Snf1 
(α-PT210). Representative Western blots are shown. D Structure of the adenosine analogue, CZ22. 
  89
cells expressing wild-type Tos3 exhibited no defect in the induction of invertase. In contrast, 
significant inhibition (85%) of invertase induction was observed in cells expressing Tos3-L135G 
exposed to the same analogue concentration. Increasing the concentration of CZ22 did not 
produce a significant improvement in the degree of inhibition. All subsequent experiments with 
Tos3-L135G used 2.5 µM CZ22. 
We observed a subtle but reproducible stimulation of invertase activity when cells 
expressing wild-type Tos3 were subjected to glucose limitation in the presence of 1 µM CZ22 
(Figure 4.4b). The mechanism by which this occurs is not clear. However, the purpose of these 
experiments was to generate a tool with which we could rapidly and efficiently shut off SAK-to-
Snf1 signaling. Here we have generated a variant of Tos3 that functions like the wild-type kinase 
but can be efficiently inhibited by the addition of low concentrations of CZ22. 
We next directly analyzed the capacity of CZ22 to prevent Tos3-L135G-mediated 
phosphorylation of Snf1 (Figure 4.4c). Cells expressing analogue-sensitive Tos3 as the only SAK 
were grown in glucose-rich media and shifted to low glucose in the presence of DMSO or 2.5 
µM CZ22. The phosphorylation state of the Snf1 activation loop as well as the level of total Snf1 
protein were assessed by Western blotting. Glucose-grown cells exhibit low-level basal 
phosphorylation. As previously reported, Snf1 becomes phosphorylated when cells are shifted to 
low glucose media for 2 h in the absence of CZ22 (129). When CZ22 is included at the shift to 
low glucose, however, Snf1 never becomes phosphorylated beyond basal levels, clearly 
demonstrating that CZ22 inhibits the activity of Tos3-L135G toward the Snf1 activation loop. 
These data establish our analogue-sensitive allele of TOS3 as a legitimate tool to study the 
regulation of Glc7-Reg1 protein phosphatase activity. 
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4.3.3 Snf1 dephosphorylation is regulated by glucose 
To test whether dephosphorylation of the Snf1 activation loop is regulated by glucose, the rate of 
dephosphorylation was measured in cells with active (phosphorylated) Snf1. In one case, de novo 
phosphorylation of Snf1 was blocked by inhibiting the sole SAK, and the rate of 
dephosphorylation in low glucose was then measured. In the second case, de novo 
phosphorylation was blocked, glucose was added back to cultures, and the rate of 
dephosphorylation upon shifting to high glucose was measured. By comparing these two 
conditions, we were able to assess whether the dephosphorylation reaction is regulated by 
glucose. In multiple experiments, we found that the rate of Snf1 dephosphorylation was strongly 
regulated by glucose. A representative experiment is shown in Figure 4.5. Cells expressing the 
sensitized Tos3-L135G kinase as the only SAK were grown in high glucose (2%) and then 
shifted for 2 h to media containing only 0.05% glucose. Snf1 activation loop phosphorylation 
status and total Snf1 protein levels were again assessed by Western blotting. The phosphorylation 
status of the Snf1 activation loop is greatly increased when cells are shifted to low glucose (lanes 
1 and 2). As a negative control, DMSO was added to the low glucose culture. When aliquots 
were removed after an additional 1, 3, or 5 min in low glucose plus DMSO, the activation loop 
phosphorylation remained stable and high (lanes 3–5). In contrast, when glucose was added to the 
cultures with or without CZ22, dephosphorylation of Snf1 to basal levels was observed after only 
1 min of glucose addition (lanes 13 and 18). Therefore, the rate of dephosphorylation upon 
glucose addition is extremely rapid (t1/2 < 0.5 min). Technical limitations prevent analysis of 
shorter time points. To assess the rate of dephosphorylation occurring in low glucose, de novo 
phosphorylation was inhibited by the addition of CZ22 to 2.5 µM. In the absence of new 
phosphorylation events, the activation loop of Snf1 retained its high level of phosphorylation 
 Figure 4.5 Activity of the Glc7-Reg1 phosphatase toward Snf1 is regulated by glucose. 
Cells expressing the analogue-sensitive Tos3-L135G as the only SAK were grown in high glucose media (H) and 
then shifted to low glucose (L) for 30 min. DMSO, CZ22 dissolved in DMSO, or glucose was added, and aliquots 
were removed after 1, 3, or 5 min. Extracts were prepared, and the HA-tagged Snf1 protein was collected by 
immunoprecipitation and analyzed by Western blotting using antibodies directed against the phosphorylated form of 
the Snf1 activation loop (α-PT210). 20 μg of protein extracts were analyzed by Western blotting against total Snf1 
protein (α-HA). 
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(lanes 8–10); therefore, the half-time for the dephosphorylation reaction in low glucose must be 
greater than 5 min. This indicates that the rate of Snf1 dephosphorylation is at least 10 times 
slower under glucose limitation than is observed under glucose abundance (compare t1/2 of <0.5 
min and >5 min). These results provide the first direct evidence that the rate of Snf1 
dephosphorylation is regulated by glucose concentration in vivo. These experiments have also 
been undertaken with the analogue-sensitive Elm1-T200G (176) with similar results (data not 
shown). 
4.3.4 Glc7-Reg1 phosphatase complex is active in low glucose 
The glucose-regulated dephosphorylation of Snf1 could occur by one of two mechanisms. First, 
glucose concentration could control the phosphatase activity of the Glc7-Reg1 complex. Second, 
glucose levels might regulate the availability of phosphorylated Snf1 as a substrate to the 
inactivating phosphatase. Supporting the latter model, in vitro experiments with purified 
mammalian proteins have shown that AMP binding to the γ subunit of AMPK decreases the rate 
of AMPK activation loop dephosphorylation (159, 179). To test whether the regulation of Snf1 
activation loop dephosphorylation is controlled by changes in Glc7-Reg1 activity or accessibility 
of the phosphatase to the Snf1 activation loop, we analyzed the glucose-regulated activity of 
Glc7-Reg1 toward another substrate, the transcription factor Mig1. 
In order to examine the activity of Glc7-Reg1 phosphatase toward Mig1 in low glucose, 
we utilized an adenine analogue-sensitive variant of Snf1, Snf1-I132G, to be described elsewhere 
(168). In a manner similar to the inhibition of Tos3-L135G by CZ22, the I132G mutation in the 
ATP-binding pocket of Snf1 rendered it sensitive to the related compound, 2NM-PP1. 
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We first tested the capacity of 2NM-PP1 to completely inhibit Snf1-I132G 
phosphorylation of Mig1 tagged with the HA epitope (161). The phosphorylation status of Mig1-
HA can be determined by anti-HA Western blotting, as phosphorylated isoforms exhibit a slower 
electrophoretic migration (185). Cells expressing Mig1-HA and either wild-type Snf1 or Snf1-
I132G were grown in high glucose, where Mig1 is normally not phosphorylated. Aliquots were 
taken, and the remainder of the cells were divided and treated with either DMSO (as a negative 
control) or 25 µM 2NM-PP1 (suspended in DMSO) for 10 min prior to and throughout the shift 
to low glucose. In cells expressing either wild-type Snf1 or Snf1-I132G, Mig1-HA was seen as 
the dephosphorylated faster migrating isoform in high glucose (Figure 4.6a, lanes 1 and 4). The 
addition of 2NM-PP1 completely blocked the ability of Snf1-I132G to phosphorylate Mig1 (lane 
6) but had no effect on the wild-type Snf1 (lane 3). The addition of DMSO did not inhibit either 
form of Snf1 kinase. Thus, the Snf1-I132G mutant is functional but can be selectively inhibited 
by 2NM-PP1. 
We next wanted to analyze the activity of the Glc7-Reg1 phosphatase toward 
phosphorylated Mig1-HA in high and low glucose. In multiple experiments, we have found that 
Mig1 is rapidly dephosphorylated in low glucose when Snf1 kinase is inactivated by 2NM-PP1. 
A representative experiment is shown in Figure 4.6a. Cells expressing the analogue-sensitive 
Snf1-I132G and Mig1-HA were grown in high glucose, shifted to low glucose for 1 h such that 
Mig1-HA would be in the phosphorylated state. Cells were treated with either DMSO, 2NM-PP1 
suspended in DMSO, or glucose for 5 min. Mig1-HA was found as the faster, unphosphorylated 
migrating form in high glucose (Figure 4.6a, lane 7) and the slower, phosphorylated migrating 
form upon shifting to low glucose (lane 8). The addition of DMSO had no effect on the Mig1-
HA phosphorylation status (lane 9). Within 5 min of the addition of glucose to the media, Mig1-
  
Figure 4.6 Glc7-Reg1 phosphatase is active toward Mig1 in high and low glucose. 
A, Phosphorylation of Mig1 was measured by Western blotting of protein extracts prepared from cells grown in high 
glucose (H) or 1 h after shifting to low glucose (L). Cells expressed either wild-type Snf1 (lanes 1-3) or the 
analogue-sensitive Snf1-I132G (lanes 4-11). Cells were treated with DMSO (D) or the Snf1 inhibitor, 2NM-PP1 
(NM), prior to and throughout the shift to low glucose as indicated (lanes 1-6). Cells were grown in high glucose (H) 
and shifted to low glucose (L) for 1 h (lanes 7 and 8, respectively). After 1 h in low glucose, cells were treated for 5 
min with the addition of DMSO (D), the Snf1-I132G inhibitor 2NM-PP1 dissolved in DMSO (NM), or glucose (G) 
(lanes 9-11), as indicated. B Cells carrying a complete deletion of the REG1 gene were transformed with low-copy 
plasmids expressing wild-type Reg1 protein (+) or empty vector (Δ). Cells also expressed HA-tagged Mig1 and the 
analogue-sensitive Snf1-L132G. Cells were grown in high glucose and shifted to low glucose to allow for 
phosphorylation of the Mig1 protein and were subsequently treated for 5 min with either DMSO (+D), 2NM-PP1 
(+NM), or glucose (+Glu), as indicated. Extracts were prepared and phosphorylation of Mig1 determined by 
Western blotting. 
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HA was quantitatively returned to the faster, unphosphorylated form (lane 11). When the de novo 
phosphorylation of Mig1 was blocked with 2NM-PP1, Mig1-HA returned to the faster, 
unphosphorylated isoform within the same 5 min (lane 10). Therefore, the Glc7-Reg1 
phosphatase is active toward Mig1 even in low glucose. These experiments demonstrate that 
Snf1 dephosphorylation by Glc7-Reg1 is regulated by glucose (Figure 4.5), whereas Mig1 
dephosphorylation is not (Figure 4.6). Taken together, these results suggest that the catalytic 
activity of the Glc7-Reg1 phosphatase is not controlled by glucose availability; rather, it seems 
the availability of phosphorylated Snf1 as a substrate for dephosphorylation by Glc7-Reg1 is 
regulated by environmental glucose concentration. 
The conclusion that the Glc7-Reg1 phosphatase is active toward one substrate (Mig1) 
under conditions where it is not active toward another (Snf1 activation loop) is based on the 
assumption that Mig1 is a direct substrate of the Glc7-Reg1 phosphatase. Although this 
conclusion is sometimes stated as if it were proven, an alternative interpretation for the effect of 
mutations in the REG1 and GLC7 genes on Mig1 phosphorylation has been noted (47). 
Mutations in REG1 and GLC7 cause hyperactivation of Snf1, which may in turn explain the 
increased phosphorylation state of Mig1. We used the analogue-sensitive allele of Snf1 to 
examine the effect of deletion of the REG1 gene on the phosphorylation of Mig1. In this way, 
any changes in the phosphorylation state of Mig1 as a result of REG1 deletion would be 
independent of the hyperactivation of Snf1. Cells expressing HA-tagged Mig1 and Snf1-I132G 
were shifted to low glucose for 1 h to allow for phosphorylation of Mig1. Cells were then treated 
for 5 min with 2NM-PP1 to inhibit the Snf1-I132G kinase activity. For controls, cells were either 
treated with DMSO or glucose (Figure 4.6b). When Snf1 kinase was inhibited by the addition of 
glucose, the dephosphorylation of Mig1 was rapid when Reg1 was present (lane 9). Deletion of 
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REG1 caused an increase in the phosphorylation state of Mig1 in both high and low glucose 
(lanes 2 and 4). When the activity of Snf1 was inhibited by the addition of 2NM-PP1, Mig1 was 
rapidly dephosphorylated (lane 7). Deletion of REG1 inhibited the dephosphorylation of Mig1 
(lane 8). Therefore, the effect of Reg1 on the phosphorylation state of Mig1 was not dependent 
on the hyperactivation of Snf1 kinase. This experiment is the first to separate the role of Glc7-
Reg1 in the dephosphorylation of Mig1 from the hyperactivation of Snf1. These data provide 
strong evidence that Glc7-Reg1 is indeed active toward Mig1 in low glucose, although it is 
largely inactive toward the activation loop of Snf1. 
4.4 DISCUSSION 
Glucose abundance regulates the Snf1 signaling pathway. The identity of the glucose signal and 
the mechanism(s) by which it is transduced to the Snf1 kinase have remained elusive. The 
phosphorylation status of the Snf1 activation loop is determined by the relative rates of 
phosphorylation by the SAKs and dephosphorylation by the inactivating phosphatase PP1 (Glc7-
Reg1). Until the present report, it has been unclear whether phosphate addition, phosphate 
removal, or both are regulated by changes in glucose availability. 
We first asked if phosphorylation of Snf1 is regulated by glucose concentration. Snf1-
dependent invertase activity was elevated in high and low glucose conditions in the absence of 
the PP1 regulatory subunit Reg1 when Sak1, Tos3, or Elm1 were present as the only SAK 
(Figure 4.1). Thus, each of the SAKs is capable of activating the Snf1 pathway in high glucose. 
Additionally, the fraction of total Snf1 that was phosphorylated was higher in glucose-rich 
conditions in reg1Δ strains than in REG1+ strains regardless of which SAK(s) was expressed 
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(Figure 4.2). These experiments support the idea that the SAKs are active independent of 
glucose, but two other possibilities existed. First, it was conceivable that the SAKs actually did 
exhibit glucose regulation but that the lower level of activity in high glucose was sufficient to 
activate Snf1 when PP1 function was disrupted. Second, the activity of the SAKs themselves 
might be regulated by PP1. These two possibilities were addressed by our third experiment; 
SAKs immunoprecipitated from extracts of cells grown in high and low glucose exhibited similar 
activity toward exogenous Snf1 kinase domain substrate (Figure 4.3). These results strongly 
suggest that the activities of the SAKs are glucose-independent. Additional lines of evidence 
supporting this idea were presented above. 
If the SAKs are not regulated by glucose, then dephosphorylation of Snf1 by Glc7-Reg1 
PP1 must be regulated by glucose. Using an adenine analogue-sensitive mutant of the SAK Tos3, 
we showed that the rate of Snf1 dephosphorylation is at least 10-fold greater in high glucose than 
in low glucose (Figure 4.5). This experiment did not distinguish between a direct effect of 
cellular energy status on the catalytic activity of the Glc7-Reg1 complex and an effect on the 
availability of the Snf1 activation loop to serve as a Glc7-Reg1 substrate. An adenine analogue-
sensitive allele of Snf1 allowed us to determine that Glc7-Reg1 was active in low glucose, 
rapidly dephosphorylating another substrate, Mig1, in conditions under which Snf1 is resistant to 
dephosphorylation (Figure 4.6). This result suggests that glucose regulation of Snf1 
dephosphorylation is achieved by controlling access of the phosphorylated Snf1 activation loop 
to PP1. 
Our model of the regulation of Snf1 activation loop phosphorylation is presented in 
Figure 4.7. The three SAKs and the PP1 phosphatase are catalytically active regardless of 
glucose availability. In low glucose, however, the phosphorylated activation loop of Snf1 is 
  
Figure 4.7 Model for the regulation of Snf1 kinase at the level of dephosphorylation. 
In high glucose media, the Snf1 kinase is largely unphosphorylated and inactive due to the accessibility of the 
activation loop threonine 210 to the Glc7-Reg1 phosphatase. Under conditions of glucose limitation, the 
dephosphorylation of the Snf1 activation loop is inhibited by an unknown factor (X), leading to the accumulation of 
phosphorylated and active Snf1 kinase. 
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protected from dephosphorylation by an unknown factor (X in our schema), allowing the 
phosphorylated isoform of Snf1 to accumulate. How might the access of phosphorylated Snf1 to 
Glc7-Reg1 be controlled? We consider here two possibilities. The first is that, in low glucose, 
phosphorylated Snf1 and Glc7-Reg1 are maintained in distinct subcellular compartments, thus 
protecting phosphorylated Snf1 from PP1. Dombek et al. (51) have reported that Reg1-GFP 
fusions display constitutively cytoplasmic localization. Snf1, by contrast, has been shown to 
exhibit a complex, glucose-regulatedsubcellular localization pattern. In glucose abundance, all 
three β subunit-specific isoforms of Snf1 are cytoplasmic (194). Upon a shift to low glucose, 
however, the Snf1-Sip1-Snf4 complex becomes localized to the vacuolar periphery, the Snf1-
Gal83-Snf4 complex becomes enriched in the nucleus, and the Snf1-Sip2-Snf4 complex seems to 
remain cytoplasmic under all conditions (83, 194). The idea that subcellular localization might 
control Snf1 dephosphorylation is challenged by the finding that the three isoforms of Snf1, each 
with a distinct localization pattern, all show similar regulation by glucose (128, 161). For this 
reason, we do not favor a model in which Snf1 dephosphorylation is controlled by subcellular 
localization. 
A second possibility is that the phosphorylated threonine 210 residue is protected from 
dephosphorylation by Glc7 in low glucose by some protein factor (X in our model; Figure 7). The 
identity of this protein factor is unclear; however, two strong candidates come immediately to 
mind. One candidate is Snf4, the γ subunit of the Snf1 heterotrimer. In the mammalian enzyme, 
the γ subunit binds AMP and inhibits the dephosphorylation reaction (159, 179). In yeast, the γ 
subunit does not appear to bind AMP, and whether or not it binds some other small metabolite is 
a topic of great interest in the field. Two-hybrid interactions between Snf1 and Snf4 are reported 
to increase in response to glucose limitation (103). It is possible that interactions of Snf1 with the 
  100
γ subunit Snf4, possibly in conjunction with the β subunits, preclude dephosphorylation by PP1 
in low glucose. It is clear, however, that although Snf4 and the β subunits are required for Snf1 
function in vivo, at least some degree of glucose regulation of Snf1 phosphorylation is 
independent of the β and γ subunits, since cells lacking either all three β subunits, the γ subunit, 
or both retain glucose-regulated phosphorylation of threonine 210 (55). In fact, when Snf1 kinase 
lacking its C-terminal regulatory domain is expressed in the absence of β and γ subunits, the 
activation loop still exhibits glucose-regulated phosphorylation (55). Thus, some regulation must 
lie outside the Snf1 regulatory domain as well as the β and γ subunits. 
The second strong candidate for X in our model is Reg1. Although Reg1 is thought to act 
as the targeting subunit for Glc7 that promotes Snf1 dephosphorylation in high glucose, it is 
possible that Reg1 maintains dual roles in Snf1 activation loop regulation. Reg1 is an abundant 
component of the Snf1 kinase complex as determined by two-hybrid analysis (121) and mass 
spectrometry (54). Furthermore, the interaction of Reg1 with the Snf1 kinase domain requires the 
activation loop threonine and is stronger in low glucose (121). In low glucose, Reg1 could 
function to protect the phosphorylated threonine 210. Some as yet unidentified signal would 
control whether Reg1 serves as protector of Snf1 activation loop phosphorylation or recruiter for 
the PP1 phosphatase. 
Additional candidates for the identity of the X factor are other proteins found in the Snf1 
complex, including chaperones and the phosphoprotein-binding 14-3-3 proteins, Bmh1 and 
Bmh2 (50, 54). Finally, the Snf1 kinase domain has been reported to dimerize in a manner that 
could make the activation loop inaccessible (139). Whether or not there is regulatory significance 
to the proposed Snf1 dimerization is unknown. Clearly, further experimentation will be needed to 
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determine precisely how glucose abundance controls Snf1 availability for dephosphorylation by 
PP1. 
Finally, the glucose signal controlling Snf1 phosphorylation status is not known. Our data 
do not distinguish between a low-glucose signal that protects Snf1 from dephosphorylation and a 
high-glucose signal that promotes its dephosphorylation. Identifying the molecular cue(s) that 
regulates Snf1 activation loop phosphorylation status is of great interest. The primary 
consequence of this study will be to redirect the focus of future investigations of Snf1 activation 
loop phosphorylation away from the regulation of phosphate addition and toward the regulation 
of phosphate removal. 
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5.0  DISCUSSION AND FUTURE DIRECTIONS 
Regulation of the Saccharomyces cerevisiae Snf1 kinase involves at least two critical 
components: phosphorylation of a conserved activation loop threonine residue at position 210 
and a strong requirement for the γ subunit, Snf4. When threonine 210 is mutated to alanine, Snf1 
is rendered catalytically inactive (60). The finding that the Snf1 activation loop is still 
phosphorylated when Snf1 has been rendered catalytically inactive by active site mutations 
indicated that one or more distinct upstream activating kinases exist that phosphorylate Snf1 (as 
opposed to Snf1 autophosphorylation) (129). 
It was hoped that the identification of Sak1, Tos3, and Elm1 as the complete complement 
of Snf1-activating kinases (SAKs) (92, 180) would rapidly lead to a clearer understanding of the 
mechanism(s) by which changes in glucose availability control Snf1 activity. Multiple 
laboratories have expended significant effort and resources toward the determination of how 
glucose levels might regulate the activity of the SAKs. Indeed, Chapters 2 and 3 of this 
manuscript detail some of the work undertaken to elucidate the regulation of the SAKs. While 
much has been learned about the relationships between Sak1, Tos3, and Elm1 and their substrate, 
Snf1, initial investigation of the SAKs may have been naïvely clouded by a prevailing kinase-
centric worldview (155). 
Importantly, a recent pair of elegant biochemical studies of mammalian AMPK 
regulation has provided strong evidence that AMPK activation loop phosphorylation is regulated 
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by dephosphorylation by PP2C rather than by phosphate addition by the AMPKKs. AMP 
interaction with the AMPK γ subunit prevented dephosphorylation of the catalytic α subunit and 
stimulated intrinsic AMPK catalytic activity but had no effect on AMPK phosphorylation by the 
AMPKKs (159, 179). The regulated availability of AMPK/Snf1 kinases to serve as phospho-
substrates for their cognate inactivating phosphatases is emerging as a shared mechanism of 
regulation. The data presented in Chapter 4 provides a broader perspective of the regulation of 
Snf1 activation loop phosphorylation in response to glucose limitation whereby the key glucose-
sensitive component is shown to be the availability of phosphorylated Snf1 activation loop 
threonine 210 for dephosphorylation by the protein phosphatase I (PP1) Glc7 and its regulatory 
partner Reg1. These yeast and mammalian studies have supported a dramatic paradigm change in 
the understanding of the AMPK/Snf1 signaling pathways. Future work will be directed toward 
understanding the mechanism of regulated Snf1 dephosphorylation. 
5.1 FUTURE DIRECTIONS: HOW MIGHT SNF1 DEPHOSPHORYLATION BE 
CONTROLLED? 
In our current model of regulated Snf1 phosphorylation, neither the catalytic activity of the 
SAKs nor that of the Glc7-Reg1 PP1 is responsive to changes in glucose availability. Rather, 
glucose levels regulate access of the phosphorylated Snf1 activation loop threonine 210 to the 
inactivating phosphatase. It will be important to determine how this regulated access occurs. One 
possibility is that regulated Snf1 access to the phosphatase is a result of differential subcellular 
localization. We do not find this likely since mutations which disrupt the low-glucose 
redistribution of Snf1 (such as deletion of the Snf1 β subunits) do not disrupt regulated Snf1 
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phosphorylation (55). A second potential mechanism for controlled Snf1 access to the 
phosphatase is the existence of a protein factor (denoted as “X” in Figure 4.7) that prevents 
Glc7-Reg1-mediated dephosphorylation of Snf1 in low-glucose conditions. A few candidates for 
the identity of Factor X are discussed below. 
5.1.1 Snf4 
Based on homology with the mammalian AMPK enzyme, the Snf1 heterotrimer γ subunit Snf4 
may seem the most likely candidate for managing access of Snf1 threonine 210 to the 
phosphatase. The mammalian γ subunit clearly plays such a role in regulating AMPK 
dephosphorylation. Mutations in the AMPK γ subunits that have been shown to cause disease in 
humans block in vitro interactions of the γ subunits with AMP (164) and compromise the AMP-
dependence of enzyme activation (42). As mentioned above, AMP binding to the human AMPK 
γ subunit has been shown to inhibit dephosphorylation by PP2C (159, 179). Finally, 
dephosphorylation of AMPK heterotrimers incorporating γ subunits with mutated ligand-binding 
sites is rendered insensitive to AMP (159). Further characterization of the role of Snf4 in Snf1 
regulation is merited. 
The AMPK γ subunits display significant sequence and structural homology across 
species. Several (but not all) of the residues implicated as critical in human γ subunit AMP 
binding are conserved in Snf4, and the recent flurry of AMPK crystallographic data provides 
compelling evidence for structural and potentially regulatory conservation as well. The 
determined structures of portions of the mammalian (45, 149, 206), S. cerevisiae (7, 139, 156, 
157), and Schizosaccharomyces pombe (105, 184) AMPK/Snf1 heterotrimers reveal striking 
conformational similarity. γ subunits of heterotrimers from mammalian AMPK, S. cerevisiae 
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Snf1, and S. pombe AMPK have all been co-crystallized with bound AMP. In the case of the S. 
cerevisiae Snf1 complex, though, it is not clear whether these interactions are physiologically 
significant or are crystallographic artifacts as AMP was included at very high concentrations in 
these crystal studies (7). 
The Snf4 protein is required for efficient Snf1 function in glucose-limiting conditions 
(32, 129), and the kinase-stimulating interaction between Snf1 and Snf4 within the heterotrimer 
is believed to be enhanced in low-glucose conditions, as two-hybrid analyses have established a 
glucose-regulated association between the Snf1 regulatory domain and Snf4 (103). It is possible 
that these interactions play some role in regulating access of the Snf1 activation loop to PP1. 
Other evidence indicates that there exists at least some Snf4-independent regulation of 
Snf1 phosphorylation. First, in cells lacking Snf4 or the β subunits (or the motifs in Snf1 
required for interaction with Snf4 and the β subunits), Snf1 phosphorylation is normally glucose-
responsive (55). Thus, in the absence of Snf4, some other mechanism exists which protects Snf1 
activation loop phosphorylation in low glucose conditions. Second, mutations in Snf1 have been 
identified that render regulated Snf1 activity independent of Snf4 (114). Snf4 may thus account 
for some regulation of Snf1 phosphorylation status, but it clearly cannot account for the entirety 
of regulatory control of activation loop phosphorylation. Third, the two-hybrid interaction of 
Snf1 and Snf4 requires Snf1 threonine 210, as Snf1-T210A does not associate with Snf4 in this 
assay (121); conversely the Snf1/Snf4 association is rendered constitutive in cells lacking Reg1 
(103). These data are consistent with Snf1 phosphorylation status regulating Snf1/Snf4 
interaction rather than vice versa. However, interpretation of yeast two-hybrid data involving 
Snf1 is complicated by the finding that recruiting an active form of Snf1 to a promoter can 
stimulate RNA polymerase II-dependent transcription (111). 
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Thus, other strategies must be employed to determine what, if any, role Snf4 has in the 
regulation of Snf1 activation loop phosphorylation status. One option is to employ both a site-
directed and randomized mutagenic approach to screen for SNF4 alleles which alter Snf1 activity 
and phosphorylation. The availability of structural and sequence information will facilitate 
homology-based prediction of residues that may be critical for Snf4-mediated Snf1 regulation. 
Site-directed mutagenesis of amino acids predicted to be involved in ligand binding and 
interaction with Snf1 may illuminate mechanisms of Snf4-to-Snf1 signaling. Once these 
mutations have been introduced to Snf4, the ability of the mutant Snf4 variants to support 
regulated Snf1 activation loop phosphorylation and signaling can be directly assayed. Similarly, 
randomized mutagenesis of Snf4 may assist in furthering our understanding of the complex 
relationship between Snf1 and Snf4. A large-scale library of Snf4 mutants can be easily 
generated and screened for Snf1 gain-of-function or loss-of-function phenotypes by assessing the 
growth of yeast expressing candidate clones in a variety of growth conditions or measuring the 
expression of a Snf1-dependent reporter construct. Following the identification of candidate Snf4 
mutants, Western blots against phosphorylated Snf1 activation loop could determine if mutant 
Snf4 proteins disregulated Snf1 phosphorylation status. 
Our research group has purified each subunit of the Snf1 heterotrimer (55) and all three 
SAKs (54). In our continuing analysis of regulated Snf1 dephosphorylation, it is now essential 
that the PP1 complex components Glc7 and Reg1 be purified. Such efforts are currently 
underway. It will be important to be able to recapitulate the dephosphorylation of Snf1 by Glc7 
in in vitro phosphatase assays. Whether Snf4 affects Glc7-mediated Snf1 dephosphorylation can 
be assayed by comparing the in vitro dephosphorylation rates of phosphorylated Snf1 in the 
presence and absence of Snf4. 
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Another open question regarding the yeast γ subunit Snf4 is whether Snf4, like its 
mammalian counterparts, binds AMP (or any ligand) in vivo. Thus far, the only biochemical 
evidence supporting AMP coordination by Snf4 are the structural studies described above in 
which AMP was included at high concentrations such that it is not clear whether these 
interactions might be reasonably predicted to occur in cells (7). Moreover, in contrast to what has 
been observed in mammalian cells, Snf1 is active under some conditions in which the AMP:ATP 
ratio is not elevated, such as when cells are forced to grow by respiration of ethanol and glycerol 
(18). It is possible that, with respect to the α/γ relationship, the yeast and mammalian enzymes 
are fundamentally different. Additional in vitro analyses have failed to confirm Snf4 interaction 
with or stimulation by AMP (130, 200). Researchers in our group have also been unable to 
observe any AMP-dependent stimulation of Snf1 holoenzyme activity in vitro (unpublished 
data), though the failure to detect AMP stimulation could conceivably be the result of Snf1 
heterotrimer purified with the putative binding sites saturated with AMP. A recent study has 
suggested that LKB1-AMPK signaling could be stimulated by the glycolytic intermediate 3-
phosphoglycerate (57). An expanded panel of potential stress-signaling ligands should be tested 
for interaction with Snf4, stimulation of Snf1 activity, and inhibition of Snf1 dephosphorylation 
by PP1.  
It may be that, in contrast to the mammalian system, Snf4 serves primarily a structural 
rather than regulatory role, being required to stabilize the active conformation of a 
phosphorylated Snf1 catalytic α subunit. It would be of interest to determine if the mammalian γ 
subunits can complement the Snf- defect of snf4Δ yeast (like the mammalian AMPKKs for 
sak1Δ tos3Δ elm1Δ yeast (93)). In the event that a mammalian γ subunit did support regulated 
Snf1 signaling, inactivating mutations which block AMP binding in the context of the 
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mammalian enzyme could be introduced, and the resultant protein could be tested for snf4Δ 
complementation. If a human γ subunit which cannot bind AMP confers normal Snf1 signaling 
in yeast, this would strongly support a structural rather than regulatory requirement for the yeast 
γ subunit. 
5.1.2 Reg1 
An intriguing candidate for Factor X that might control access of Snf1 to the inactivating 
phosphatase is Reg1. This may seem counterintuitive, since Reg1 is required to target Glc7 to 
Snf1 for dephosphorylation in high-glucose conditions (121, 160). However, Reg1 is found in 
complex with Snf1 in both abundant and limiting glucose growth conditions. In fact, in their 
analysis of the regulatory interactions between Reg1 and Snf1, Ludin et al. found that two-hybrid 
Reg1/Snf1 interactions were strengthened in low glucose when Snf1 is normally phosphorylated 
and active (121). Co-immunoprecipitation experiments in our laboratory have confirmed these 
observations (unpublished data). Thus, we consider the possibility that Reg1 serves a dual role in 
controlling Snf1 activation loop phosphorylation status: targeting Glc7 to Snf1 in high glucose 
and protecting the phosphorylated Snf1 activation loop from dephosphorylation in low glucose. 
To explore this hypothesis, a randomized mutagenic screen for Reg1 mutants that result 
in disregulated Reg1/Snf1 association and disregulated Snf1 activation loop phosphorylation 
should be undertaken. As described above in experiments proposed to identify Snf4 loss- or 
gain-of-function mutants, growth on defined carbon sources as well as expression of Snf1-
dependent reporter constructs may facilitate the identification of such Reg1 variants. Mutant 
Reg1 candidates selected for additional analysis would then be assayed for association with Snf1 
and for the aberrant regulation of Snf1 phosphorylation. The Reg1 dual-role model would be 
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supported, for instance, if cells expressing Reg1 mutants that interact more strongly with Snf1 in 
high glucose exhibit constitutive Snf1 activation loop phosphorylation. In vitro studies could also 
facilitate a better understanding of Reg1’s role in controlling Snf1 phosphorylation. Once Glc7 
and Reg1 have been purified, in vitro phosphatase assays of Snf1 by Glc7 can be performed in 
the presence or absence of Reg1 protein. Additionally, a panel of potential metabolic signaling 
molecules can be tested for their effect on these in vitro reactions. 
Elevated Reg1/Snf1 two-hybrid interaction in low glucose remains intriguing in light of a 
Reg1 dual-role model. As was the case for Snf4, the association of Reg1 and Snf1 requires 
threonine 210 (121). It may be that the protective role of Reg1 is initiated when Reg1 recognizes 
and tightly binds the phosphorylated threonine. However, Reg1/Snf1 association is constitutive 
and glucose-independent when the Snf1 ATP-binding pocket is mutated (lysine 84 mutated to 
arginine) (121). Snf1-K84R is catalytically inactive, and this result suggests that Snf1 negatively 
regulates its own association with Reg1. The position of Reg1 in Snf1 signaling is not yet clear, 
and much work is likely to focus on this important protein. 
5.1.3 Bmh1/Bmh2 and Ssb1/Ssb2 
Other conceivable candidates for a protein factor which might play a role in the regulation of 
Snf1 activation loop phosphorylation are those which have been found in complex with purified 
Snf1 (54). Two such proteins are the yeast 14-3-3 proteins, Bmh1 and Bmh2. 14-3-3 family 
members bind phosphoproteins and have been shown to have diverse roles in other signal 
transduction pathways (63). It would be of interest to determine what, if any, role they might 
play in controlling Snf1 activation loop phosphorylation. One group has suggested these proteins 
may interact genetically and biochemically with Reg1 in maintaining glucose repression of Snf1-
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dependent signaling (50). Analysis of these proteins is complicated by the fact that deletion of 
both Bmh proteins is lethal in yeast (69); thus, a more subtle analysis would be required to 
further explore the potential role they might play in regulating Snf1. Two other proteins found to 
interact with both Snf1 and Reg1 are the heat shock proteins Ssb1 and Ssb2 (50, 54). A minor 
role for these proteins in glucose repression has been observed (50), though it is unlikely that 
they account for a significant portion of the regulation of Snf1 phosphorylation. 
5.1.4 Hxk2 
The role of Hxk2 in glucose repression and Snf1 signaling has been controversial. Hxk2 is one of 
three hexose kinases (the others are Glk1 and Hxk1) that phosphorylate intracellular glucose in 
the first irreversible step of glycolysis following glucose uptake; of these three enzymes, Hxk2 
provides the bulk of glucose kinase activity (15, 37, 195). Cells which lack Hxk2 display 
constitutive Snf1 signaling regardless of glucose levels (103). A simple interpretation of these 
data is that in the absence of Hxk2, a significant fraction of glucose phosphorylation is lost, 
drastically limiting the flux through glycolysis and hence causing cells to respond as if there 
were limited glucose present. One group, however, has described roles for Hxk2 in physically 
bridging the interaction between Snf1 and its substrate, Mig1, as a mechanism of regulating Snf1 
signaling (5) and in the regulation of Mig1-dependent transcriptional repression of SUC2 (4), 
leading them to propose that Hxk2 plays a role in signaling glucose abundance distinct from its 
glucose phosphorylation activity. It may be instructive to analyze whether Hxk2 can contribute 
to the regulation of Snf1 activation loop phosphorylation status. 
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5.1.5 Other nutrient-sensing pathways: TOR, HXT, and PKA pathways 
The Snf1 signaling axis is not the only cellular network that is responsive to changes in nutrient 
availability. The TOR (Target of Rapamycin) signaling pathway is stimulated by nutrient 
abundance (46). While both yeast and mammalian TOR kinases are upregulated by high 
concentrations of glucose and nitrogen (11), the yeast TOR system is less well characterized than 
the mammalian network. The mammalian AMPK seems to function upstream of the TOR 
kinases, since, under conditions of energy limitation, AMPK phosphorylates and activates the 
TOR inhibitor, TSC2 (99, 109). Moreover, mammalian AMPK has recently been shown to 
phosphorylate the TOR-interacting protein, raptor.  Phosphorylated raptor binds 14-3-3 protein 
in a manner that inhibits raptor-associated TOR kinase activity (74). These studies indicate that 
AMPK modulates mammalian TOR kinase activity by regulating the functions of multiple 
upstream targets. 
 The picture in yeast is not so clear. One study positioned Snf1 downstream of TOR in 
regulating filamentous growth in response to nitrogen availability (143). Another showed that 
Snf1 and TOR signaling independently converge in regulating the phosphorylation status of the 
transcriptional activator Gln3 (14). A third report further established a connection between the 
Snf1 and TOR pathways in regulating transcription of INO1 in response to inositol limitation. 
Deletion of the SNF1 gene resulted in decreased TBP binding of the INO1 promoter and INO1 
transcription; deletion of the gene encoding the Sit4 phosphatase partially suppressed this snf1Δ 
phenotype. TOR signaling appeared to inhibit the repressive effect of Sit4 on INO1 transcription 
(170). Whether the Snf1 and TOR signaling pathways directly regulate the same targets or if one 
is subject to direct regulation by the other is not clear. Given the ambiguity of data regarding the 
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relationship between Snf1 and TOR kinases in yeast (Tor1 and Tor2), the possibility that the 
TOR pathway might regulate Snf1 activation loop phosphorylation status should be investigated. 
Glucose levels control expression of genes in the hexose transporter (HXT) family, which 
possess a range of affinities for glucose and allow for its uptake by facilitated diffusion (144). 
Two members of this family, Rgt2 and Snf3 exhibit the conserved 12-transmembrane domain 
structure but function as glucose sensors rather than sugar transporters (117). Rgt2 and Snf3 
sense high and low glucose levels, respectively, and signal glucose abundance via their C-
terminal cytoplasmic domains not present among the other HXT proteins (39, 144, 190). The 
proteins Std1 and Mth1 repress the transcription of genes encoding particular hexose transporters 
when bound to the cytoplasmic tails of Rgt2 and Snf3, respectively (162). Std1 and Mth1 
inhibition of HXT expression is mediated by interaction with the transcription factor Rgt1 (113). 
The net effect is the expression of low-affinity glucose transporters under conditions of glucose 
abundance and high-affinity transporters when glucose is limiting. While there may be some 
interaction or cross-talk between this and the Snf1 signaling pathway, it is improbable that Rgt2, 
Snf3, or their downstream effectors control access of phosphorylated Snf1 to the Glc7 PP1, as 
Snf1 activity is normally glucose-regulated in cells lacking Rgt2, Snf3, Std1, and Mth1 (162). 
The protein kinase A (PKA) signaling pathway also responds to glucose levels. In short, 
the glucose/sucrose-sensing G-protein coupled receptor Gpr1 signals via the G protein Gpa2 
(116) to activate adenylate cyclase, which catalyzes the generation of cAMP (38). cAMP 
promotes PKA activation by binding the inhibitory PKA regulatory subunit Bcy1, resulting in its 
dissociation from and activation of one of three redundant PKA catalytic subunits, Tpk1, Tpk2, 
or Tpk3 (106, 183). While the PKA signaling pathway may regulate the subcellular localization 
of one β-subunit Snf1 isoform (Snf1-Sip1-Snf4) (85), cells with defective PKA signaling display 
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ordinary glucose regulation of Snf1-dependent invertase activity, indicating that neither PKA nor 
its pathway components are the key factor(s) controlling Snf1 activation loop phosphorylation 
status (96). 
5.1.6 Snf1 dimerization 
An unanticipated structural feature emerged in several of the published Snf1/AMPK crystal 
structures: dimerization. In a 2005 study, the non-phosphorylated Snf1 kinase domain 
crystallized in a homodimeric asymmetric unit with a helix of one molecule inserted into the 
active site cleft between the N- and C-terminal lobes of the other (156). A subsequent structural 
analysis of the Snf1 kinase domain revealed a homodimerization conformation which resulted in 
the activation loop threonine 210 being buried and presumably inaccessible to Snf1-activating 
kinases (139). Portions of the Snf1/AMPK complexes of both S. cerevisiae and S. pombe were 
crystallized as dimers of heterotrimers, though the interface of dimerization was different for the 
two species’ enzymes: the dimerization interface of S. cerevisiae Snf1 heterotrimer was between 
the Snf4 γ subunits of each heterotrimer (7), while the S. pombe enzyme dimerized via reciprocal 
α/γ interactions (184). Unfortunately, the crystallized heterotrimers include the catalytic α 
subunit C-terminal regulatory domain but not the N-terminal kinase domain, making it more 
difficult to extrapolate biological and regulatory significance from these structures. Very 
recently, light scattering analysis of bacterially expressed and purified mammalian heterotrimeric 
AMPK provided evidence of homodimerization, but only at high concentrations. At 
concentrations closer to predicted physiological levels, AMPK existed as monomers of 
heterotrimers in solution (152). 
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 We have not observed evidence of multimerization of the Snf1 heterotrimer. In size 
exclusion chromatography experiments, components of the Snf1 complex have eluted in 
fractions predicted to contain a complex of a molecular mass consistent with that of single 
heterotrimers (155 kDa) (55). It is possible that the Snf1 enzyme does in fact incorporate into 
dimers of heterotrimers in high-glucose conditions and that these dimers might dissociate into 
their constituent heterotrimers upon cell harvesting and/or protein extraction. Experiments in 
which cells are treated with cross-linking agents to preserve complex integrity before harvesting 
and protein extraction might enable more sensitive detection of higher order Snf1 complexes. If a 
dimer of heterotrimers is in fact observed in vivo, then its effect upon Snf1 phosphorylation 
status can be further investigated. Further, randomized mutagenic two-hybrid screens could then 
be designed to identify mutations in α, β, or γ subunits that alter dimerization dynamics. Other 
candidates (described above) for Factor X may be explored for roles in mediating or preventing 
glucose-regulated dimerization. 
5.1.7 Snf1 ubiquitination  
A very recent study has explored polyubiquitination as a novel regulatory mechanism for AMPK 
and AMPK-related kinases in mammalian cells. When the deubiquitinating enzyme USP9X was 
knocked down or inhibited, polyubiquitination of AMPK and two AMPK-related kinases 
(NUAK1 and MARK4) kinases was observed. The unusual lysine 29- and lysine 33-linked 
ubiquitin chains (lysine 48 and lysine 63 linkages are more commonly observed) did not affect 
protein stability; rather, the ubiquitin modifications inhibited LKB1-mediated phosphorylation of 
the activation loop threonine residues of NUAK1 and MARK4. While the residue(s) to which 
ubiquitin was conjugated was not determined, a conserved tryptophan within the kinase domains 
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of these proteins was determined to be required for the removal of the polyubiquitin chain(s) (6). 
This tryptophan is conserved in Snf1 (at position 305). To my knowledge, ubiquitination as a 
possible regulatory mechanism for Snf1 activation or activity has not been explored. Further, 
Snf1 mono- or polyubiquitination might not be detected by Western analysis if deubiquitinating 
enzymes are not inhibited during yeast protein extraction. We have mutated tryptophan 305 to 
alanine and have not observed a defect in Snf1-dependent growth on alternative carbon sources 
in preliminary analysis (unpublished data). It could be that Snf1 polyubiquitination is required 
for Snf1 repression in high-glucose conditions rather than for Snf1 activation in low-glucose. 
Ubiquitin conjugation may indeed represent an important component of signaling to the Snf1 
activation loop, and more subtle functional and biochemical analysis is warranted. 
5.2 SNF1 AND AMPK: COMPARED AND CONTRASTED 
The work described herein and performed by others studying Snf1 and AMPK illuminate 
similarities and differences between the mammalian and yeast pathways. Several components 
and characteristics of these pathways have been highly conserved, justifying aggressive research 
into both pathways. Certainly, findings in each system have contributed to a broader 
understanding of the mechanisms regulating the response to energy limitation. On several 
occasions, findings in one field have facilitated discoveries in the other. Investigation of this 
pathway in a variety of model organisms will accelerate the elucidation of events upstream of 
AMPK/Snf1 activation. 
 The active form of both enzymes is heterotrimeric, consisting of a catalytic α subunit and 
regulatory β and γ subunits, and recent crystallographic information confirms a highly conserved 
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structural arrangement. Many of the mammalian AMPK and yeast Snf1 substrates have been 
conserved. Both kinases require at least two events for full activation: activation loop 
phosphorylation by related upstream kinases and a distinct step mediated by the γ subunit. While 
the nutrient-regulated activation loop phosphorylation of both AMPK and Snf1 were long 
presumed to be a reflection of the regulatory status of their respective upstream activating 
kinases, recent work in both fields has shown the opposite to be true. The AMPKKs and SAKs 
appear to be constitutively active, while dephosphorylation of AMPK and Snf1 by their 
respective inactivating phosphatases seems to be responsive to changes in energy status. 
 The differences between AMPK and Snf1 signaling have emerged over the past several 
years. For one, the existence of multiple genes encoding each AMPK subunit and the possibility 
of splicing variants therein renders AMPK inherently more complex than Snf1. Second, while 
each enzyme requires the γ subunit for efficient in vivo function, only AMPK γ subunits have 
been shown to bind and be activated by the ligand AMP. Little evidence is currently available to 
suggest that Snf4 is similarly responsive to AMP (or any other ligand). Third, the active form of 
the primary AMPKK, LKB1, is, like its substrate, a heterotrimer, composed of LKB1, and two 
auxiliary subunits, the pseudokinase STRAD and stabilizing interacting partner MO25. Yeast 
SAKs do not appear to function as oligomers. There are no known pseudokinases in yeast, and 
the yeast homologue of MO25, Hym1, is not found in complex with any of the SAKs (54). 
Fourth, while activation loop dephosphorylation is regulated by energy status in both systems, 
members of different phosphatase families dephosphorylate their respective substrates: PP2C is 
the major AMPK-inactivating phosphatase, while the Glc7-Reg1 PP1 is the primary Snf1-
inactivating phosphatase. It remains to be seen, then, if the mechanisms controlling regulated 
activation loop dephosphorylation are conserved. If, as discussed above, the yeast γ subunit Snf4 
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is implicated in controlling threonine 210 phosphorylation status, this would indicate strong 
conservation of dephosphorylation regulation, since AMP binding to mammalian γ subunits 
inhibits dephosphorylation by PP2C. If, by contrast, Reg1 or an unrelated protein emerges as the 
key factor in inhibiting Snf1 activation loop dephosphorylation in nutrient limitation, this would 
represent a significant divergence in the regulation of this signaling module. The similarity or 
difference of other factors remains to be seen. For example, it is yet to be determined whether 
Snf1 is polyubiquitinated in a manner similar to the mammalian enzyme. 
5.3 CONCLUDING REMARKS 
The scientific process is an intellectually gratifying endeavor. It allows the curious individual to 
study phenomena, make observations, generate explanatory hypotheses, and design experimental 
strategies to test these hypotheses. Inevitably, the confirming or refuting of any particular 
hypothesis spawns novel observations, hypotheses, and experimentation. Such has clearly been 
the case in the study of the regulation of the Snf1 signaling pathway as detailed in the preceding 
pages. The discovery of three Snf1-activating kinases led to the generation of several hypotheses 
describing the mechanisms by which Sak1, Tos3, and Elm1 are regulated by glucose availability. 
The ensuing work led to the detailed analysis and characterization of these proteins and an 
unexpected discovery: these three SAKs displayed constitutive activity toward their substrate, 
Snf1. We then hypothesized and confirmed that Snf1 dephosphorylation represented the major 
regulatory node in the control of Snf1 activation loop phosphorylation status. We are now faced 
with a new question: How is Snf1 dephosphorylation controlled by glucose levels? This question 
will be followed by new hypotheses, a few of which are described above, and new experimental 
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designs. The process is naturally regenerative: the cycle repeats over and over, and the 
inquisitive mind will never exhaust the vast store of phenomena present in all of creation. 
In addition to the personal satisfaction of scientific investigation, participating in basic 
biomedical research is a venture beneficial to humanity at large, elevating those who participate 
in and reap the benefits of this labor. Discoveries made at the laboratory bench contribute 
directly and indirectly to our understanding of human health and disease and pave the way for 
improved preventative behavior and treatments. The AMPK signaling pathway is emerging as an 
integral component of multiple areas of human health. It is hoped that the work presented in this 
dissertation will contribute to improved understanding and treatment of diabetes and other 
metabolic disorders, heart disease, and cancer. 
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